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ABSTRACT 
Vitamin D (vit. D) deficiency is common during pregnancy (Holick, et al., 2011). 
Supplementation of vit. D has shown to protect against complications and adverse outcomes 
during pregnancy (De-Regil LM, 2016). A comprehensive literature search and review was 
conducted to locate articles related to pregnancy outcomes. The literature review found thirteen 
studies related to vit. D and impact on pregnancy, twenty-five studies examined adverse 
pregnancy outcomes related to vit. D deficiency and eight studies examined current vit. D intake 
among pregnant women.  
Evidence shows a positive association between vit. D deficiency and pregnancy, 
suggesting that vit. D sources require closer examination and recommendations for pregnant 
women and women of childbearing age. Evidence shows mixed results with correlation of vit. D 
deficiency to adverse pregnancy outcomes. Vitamin D supplementation has shown to contribute 
to total vit. D intakes and shows adequate increases in serum 25-hydroxyvitamin-D (25(OH)D) 
levels with supplementation. 
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CHAPTER 1. INTRODUCTION 
Overview of Topic 
The Institute of Medicine (IOM) updated the Dietary Reference Intakes (DRI) in 2010 for 
vit. D and calcium. This came after the United States (US) and Canadian governments requested 
a review of recent research and data pertaining to calcium and vit. D requirements. The DRI are 
established for the public health and the health of the general population living in the U.S. and 
Canada. More specifically vit. D has been the center of attention in the past 10 years for its 
possible importance in human health. The relationship of vit. D to several health outcomes has 
been suggested by researchers in the scientific community, and range from prevention of 
diabetes and cancer to increased immunity and the reduction of falls among the elderly related to 
muscle quality. During pregnancy, a low vit. D status can be detrimental to mother and fetus and 
cause an infant to be vit. D deficient. Maternal vit. D deficiency can lead to pre-eclampsia, 
cesarean section delivery, gestational diabetes and excess risk for low birth weight for gestational 
age (Finer, et al., 2012).   
 In 2010 the IOM committee concluded that skeletal health provided the only contributing 
outcome for establishing the DRI for calcium and vit. D. There was sufficient dose-response 
evidence available to meet the criteria as a health outcome indicator and support the development 
of the DRI. Bone health was then the outcome and basis for the 2011 Estimated Average 
Requirement (EAR) and Recommended Dietary Allowance (RDA) for those older than 1 year 
(Ross, et al., 2011).  
 The American College of Obstetricians and Gynecologist (ACOG) acknowledges that 
during pregnancy severe vit. D deficiency has been associated with biochemical evidence of 
disordered skeletal homeostasis, congenital rickets and fractures in newborns. Their opinion is 
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that evidence is currently insufficient to support routine screening of pregnant women for vit. D 
deficiency. They do support screening among women thought to be at increased risk of vit. D 
deficiency, with interpretation of results in the context of the individual clinical circumstances. 
The ACOG committee opinion is to supplement with 1,000-2,000 IU of vit. D per day, 
depending on level of deficiency. This amount is safe for consumption among pregnant women 
(ACOG, 2011). The committee also noted that higher dose regimens have not been studied in 
pregnancy. Their final recommendations now are to forgo vit. D supplementation among 
pregnant women beyond what is contained in a prenatal vitamin of 400-600 IU, until more 
randomized clinical trials are completed. When the opinion of the committee was written in 
2011, reaffirmed in 2015, they found that there is insufficient evidence to recommend vit. D 
supplementation for the prevention of preterm birth or preeclampsia (ACOG, 2011).   
The DRI provide recommendations for adequate and safe daily intakes of nutrients that 
are consumed over many years and possibly over a lifetime. The DRI are a nutrient reference 
value used by many health practitioners including Registered Dietitian Nutritionists (RDNs). The 
DRI components include the Estimated Average Requirement (EAR), Recommended Daily 
Allowance (RDA), Tolerable Upper Intake Level (UL) and the Adequate Intake (AI). The EAR 
is the average daily requirement for a nutrient. The RDA, which is derived from the EAR, likely 
meets or exceeds the requirement for 97.5 percent of the population. The UL is the highest 
average daily intake that will likely pose no risk or adverse effects to most individuals in the 
general population. The AI, used when the EAR/RDA cannot be developed, is based on observed 
or experimental intakes. The final DRI indicators for calcium and vit. D were selected based on 
the strength and quality of the evidence currently available (Table 1) (Institute of Medicine, 
2011). 
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Table 1 
IOM vs. ACOG Committee Opinion Recommendations on Vitamin D Intake among Pregnant 
Women 
ACOG Committee Opinion (IU/day) IOM Recommendations (IU/day) 
400-600 600 
1,000-2,000 safe upper limit 4,000 upper level intake 
 (ACOG, 2011) (Institute of Medicine, 2011) 
Vitamin D as a nutrient can be synthesized by the human body through the action of 
sunlight or exogenous sources (e.g. food). This dual component of sun exposure and oral intake 
made it challenging to establish the DRI values (Institute of Medicine, 2011). Another challenge 
was using bone health as the basis of establishing the DRI for calcium and vit. D. There is an 
underlying assumption that the DRI for calcium are reliant on the DRI for vit. D and vis-versa. 
The requirement for one nutrient assumes that the need for the other nutrient is being fully met. 
One example the IOM committee gives is when there is inadequacy of one nutrient, this might 
cause changes in the efficient handling of, or physiological response to the other nutrient that 
might not otherwise be present. When there is a state of vit. D deficiency with minimal calcium 
intake, absorption of calcium from the gut cannot be enhanced. In this situation, there is 
accelerated conversion of 25-hydroxyvitamin D (25(OH)D) to the active form, calcitriol, through 
an increase in parathyroid hormone (PTH) levels. These types of situations can confuse the 
estimation of the true requirement under neutral circumstances, again making it difficult to 
establish a DRI (Institute of Medicine, 2011). 
Statement of Purpose 
 The IOM committee has made recommendations on what the intake of vit. D should be 
for the public and specifically during pregnancy. This paper examined the current 
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recommendations for vit. D and how that compares to what pregnant women are taking and what 
new research is saying after 2011. It examined adequacy and deficiency of vit. D during 
pregnancy, sources of vit. D and optimum levels of vit. D.  
Brief Review of Literature 
 In 2010 the IOM set the RDA for vit. D at 600 IU per day for pregnant women (Institute 
of Medicine, 2011). Studies have shown that vit. D deficiency is common during pregnancy, 
suggesting that a higher amount may be required during this time. Vitamin D deficiency during 
pregnancy has been associated with increased risk of preterm birth, preeclampsia, cesarean 
section delivery, gestational diabetes mellitus and risk for having small for gestational age 
infants (Finer, et al., 2012). 
 Several studies examined in this paper have concluded that vit. D supplementation during 
pregnancy will raise 25(OH)D levels and that adequate levels of vit (Hollis, Johnson, Hulsey, 
Ebeling, & Wagner, 2011). D during pregnancy might reduce risk for preterm birth, 
preeclampsia and low birth weight. High concentrations of vitamin D are not found in many 
foods and prenatal supplements usually contain 400 IU. One of the main sources of vit. D 
include sunlight exposure which can be dependent on many things. Factors include skin color, 
amount of skin exposed, duration of exposure, use of sunscreen and latitude. It is thought that vit. 
D supplementation throughout pregnancy is needed to achieve adequate serum 25(OH)D levels 
to benefit maternal and fetal health. Some studies suggest that 4,000 IU per day should be taken 
by pregnant women so all women, regardless of race, attain optimal nutritional and hormonal vit. 
D levels throughout their pregnancies (Hollis, Johnson, Hulsey, Ebeling, & Wagner, 2011).  
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Importance of Vitamin D during Pregnancy 
During pregnancy, low vit. D status can be associated with increased adverse outcomes 
for the mother and infant. Vitamin D is important during pregnancy because the fetus relies on 
the mother as a source during development. Studies have shown that vit. D status among the 
mother correlates to the vit. D status of the infant (De-Regil LM, 2016). Vitamin D function 
during pregnancy can also have potential effects on certain systems including immune, 
pancreatic, musculoskeletal and cardiovascular function along with neural development (Hollis, 
Johnson, Hulsey, Ebeling, & Wagner, 2011).  
 During pregnancy vit. D facilitates crucial transfer of calcium from the mother to child 
for proper skeletal development (Finer, et al., 2012). Finer et al. (2012) also suggested that 
maternal vit. D deficiency may cause increased risk of developing preeclampsia, cesarean section 
delivery, gestational diabetes and low birth weight for gestational age (Finer, et al., 2012). 
Neonatal vit. D levels are also dependent on the maternal vit. D status at delivery (Marshall, 
Mehta, & Petrova, 2013). vit. D status is proposed to influence brain development and neonatal 
immune function (Roth, et al., 2013). Finer et al. (2012) suggest conflicting results and highlight 
the need for further investigation and consideration of the complex relationship between vit. D 
status and ethnicity, complex dietary, lifestyle and social factors (Finer, et al., 2012). Other 
studies cite insufficient evidence to either support or refute the benefits of supplemental vit. D 
during pregnancy (Roth, et al., 2013).  
What is Considered Adequate during Pregnancy? 
The IOM considered the unique changes in physiology and nutrition needs that occur 
during pregnancy. When they considered the framework for the DRI they looked at the following 
factors: the need of the fetus during pregnancy, adaptation to increased nutrient demands such as 
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increased absorption and conservation of several nutrients, and the net loss of nutrients due to 
physiological mechanisms regardless of one’s intake. The IOM also stated that, since during 
pregnancy there is an increase in absorption, conservation and net loss of nutrients that there 
might not be a basis for setting reference values for pregnant women that are different from 
values set for other women of the same age. The IOM concluded that the EAR for vit. D intake 
in pregnancy is 400 IU, the RDA is 600 IU and the UL is 4,000 IU (Institute of Medicine, 2011).  
The Clinical practice guidelines from the Endocrine Society suggest that pregnant and 
lactating women require 600 IU of vit. D per day and recognize that at least 1,500-2,000 IU per 
day of vit. D might be needed to maintain serum 25(OH)D levels above 30 ng/ml. They suggest 
that maintenance tolerable upper limits of vit. D should not be exceeded without medical 
supervision, which is 4,000 IU of vit. D per day for everyone over the age of 8 years. They also 
recognize that higher levels up to 10,000 IU of vit. D per day for children and adults 19 years 
and older may be needed to correct vit. D deficiency. They suggest that all adults who are vit. D 
deficient be treated with 50,000 IU of vitamin D2 (vit. D2) or vitamin D3 (vit. D3) once a week 
for 8 weeks or the 6,000 IU equivalent of vit. D2 or vit. D3 daily for 8 weeks to achieve serum 
25(OH)D levels above 30 ng/ml. This is then followed by a maintenance therapy dose of 1,500-
2,000 IU per day (Holick, et al., 2011).  
Research Findings Since 2011 about the Adequacy of Vitamin D during Pregnancy 
 Several studies since 2011 have been conducted on what intake of vit. D is considered 
adequate. Many of those studies concluded that the current recommendations of 600 IU per day 
of vit. D is not effective at achieving adequate circulating serum levels of 25(OH)D. One study 
by Hollis et al. (2011) found that supplementing with 4,000 IU of vit. D per day for pregnant 
women was safe and the most effective in achieving sufficiency among not only pregnant 
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women, but their offspring regardless of race (Hollis, Johnson, Hulsey, Ebeling, & Wagner, 
2011). Another study by Roth et al. (2013) concluded that doses upwards of 35,000 IU of vit. D 
per week may be used in research to help identify effects and safety of vit. D supplementation 
among pregnant women (Roth, et al., 2013). Mir et al. (2017) found that supplementation of 
2,000 IU per day of vit. D or the monthly equivalent dose is more effective in achieving a higher 
vit. D level throughout pregnancy without an increase in the risk of toxicity to the mother or 
neonate (Mir, et al., 2017). Aghajafari et al. (2016) demonstrated that the current RDA of 600 IU 
of vit. D per day might not be enough to achieve a vit. D status above 30 ng/ml among some 
pregnant women who reside at higher latitudes. Researchers felt that recommendations for 
pregnant women needed to be re-evaluated (Aghajafari, et al., 2016). Hollick et al. (2011) 
suggested that pregnant and lactating women require 600 IU of vit. D per day and recognize that 
1,500-2,000 IU per day of vit. D might be needed to maintain serum levels of 25(OH)D above 30 
ng/ml (Holick, et al., 2011). They also suggested that dosing at upper limits (UL) of vit. D only 
be exceeded with medical supervision. There appears to be a disconnect between the IOM and 
ACOG’s definitions of adequate intake of vit. D compared to what research suggests is adequate 
after 2011. 
Objectives 
1) Using evidenced based research, examined current recommendations of vit. D intake 
during pregnancy vs. recommendations after 2011 during pregnancy for vit. D intake.   
2) Examined why adequate vit. D is important during pregnancy, screening for adequacy 
and deficiency of vit. D during pregnancy, sources of vit. D and optimum levels of 
vit. D. 
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Significance of Review 
Women of childbearing age and healthcare professionals would benefit from knowing 
what the current recommendations are for vit. D intake to help prevent potential adverse effects 
deficiency might have on pregnancy. This review provides guidance on current 
recommendations for vit. D among pregnant women and what the most recent research suggests 
is adequate after 2011. It also examined adequacy and deficiency of vit. D during pregnancy, 
sources of vit. D and optimum levels of vit. D. 
Definitions of Terms 
Dietary Reference Intake (DRI): The general term for a set of reference values used to 
plan and assess nutrient intakes of healthy people. These values that vary by age and gender 
include the Recommended Dietary Allowance, Adequate Intake and Tolerable Upper Intake 
Level (National Institutes of Health, 2014).  
Estimated Average Requirement (EAR): The estimated median requirement that is used 
for applications related to planning and assessing intakes for groups of people (Institute of 
Medicine, 2011). 
Adequate Intake (AI): The adequate intake (AI) was established when evidence is 
insufficient to develop an RDA and is set at a level that is assumed to ensure nutritional 
adequacy (National Institutes of Health, 2014).  
Recommended Dietary Allowance (RDA): The average daily level of intake sufficient to 
meet the nutrient requirements of nearly all (97%-98%) of healthy people (National Institutes of 
Health, 2014).  
Upper Intake Level (UL): The maximum daily intake unlikely to cause adverse health 
effects (National Institutes of Health, 2014).  
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25-hydroxyvitamin D (25(OH)D): Also known as calcidiol, made in the liver and 
converted to this from vit. D3 (cholecalciferol) and vit. D2 (ergocalciferol) (Lundqvist, 
Sandstrom, Stenlund, Johansson, & Hultdin, 2016).  
International Unit (IU): It is a measurement based on biological activity or effect; 1 IU of 
vit. D is defined as the activity of 0.025 µg of cholecalciferol in bioassays with rats and chicks. 
Conversions for vit. D3: 1 IU (International Unit) = 0.025 microgram (µg) cholecalciferol 
or ergocalciferol (Health, 2015). 
Steps to Conducting Review 
EBSCO host was searched due to being available through the NDSU library website. 
Search one used “vitamin D” and “pregnancy” as search terms that had full text, references 
available, and were peer reviewed between January 2011 and December 2017. Search one 
document types were article, language English, all publication types with pdf full text. Initially 
with search one there were 249 results. These were narrowed down to articles that were related 
to pregnancy only. Search two had the same search criteria, but used “vitamin D” and “maternal” 
instead of “pregnancy”. There were 1675 results initially. Results were narrowed down to 
articles that related to pregnancy only. There were several articles also taken from the references 
of articles found in search one and two (Figure 1). 
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Figure 1. Steps to Conducting Review 
Organization of Remaining Chapters 
Chapter Two contains a review of the literature examining the following topics: Current 
recommendations on vit. D intake during pregnancy, sources of vit. D, sun exposure, vit. D 
storage, optimum serum levels of vit. D, vit. D deficiency and impact on pregnancy, and current 
intake among pregnant women of vit. D. A thorough literature search was conducted initially in 
2014, and then repeated in 2015, 2016 and 2017. Chapter Three contains discussion and 
conclusions derived from the literature review. It also contains recommendations for future 
research and recommendations for pregnant women. Finally, all references were cited after 
chapter 3. 
  
EBSCO Host
Search 1: "Pregnancy" 
and "Vitamin D"
Search 2: "Maternal" 
and "Vitamin D"
Search Terms: full text, 
references available, 
and were peer reviewed
Dates: January 2011-
December 2017
Doctument Types: 
Article, language-
English, all publications 
types with pdf full text
Search 1: 249 Results Search 2: 1,675 results
Narrowed down by 
artciles only pertaining 
to pregnancy; 37 total 
articles
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CHAPTER 2. REVIEW OF LITERATURE 
Vitamin D 
Vitamin D also known as the sunshine vitamin, was first recognized in the early twentieth 
century. It is identified now as a prohormone and can be synthesized by the human body through 
action of sunlight. Vitamin D is also known as calciferol. There are two major forms, vit. D2 and 
vit. D3. Vitamin D2 is a 28-carbon molecule that originates from ergosterol, known as 
ergocalciferol and a component of fungal cell membranes (Alshahrani & Aljohani, 2013). 
Vitamin D3 is a 27-carbon derived from cholesterol, known as cholecalciferol, and is 
synthesized in the skin of humans from 7-dehydrocholesterol. Vitamin D3 can also be consumed 
in the diet through animal-based foods. Both forms of vit. D are synthesized commercially and 
can be found in dietary supplements and fortified foods (Institute of Medicine, 2011).  
Vitamin D2 and D3 differ only in their side chain structure, this difference does not affect 
metabolism (also known as activation) and both forms function as prohormones. Vitamin D in 
D2 or D3 form are considered biologically inactive until they undergo two reactions. These two 
reactions are enzymatic hydroxylation reactions. The first reaction takes place in the liver and is 
mediated by 25-hydroxylase, which then forms 25-hydroxyvitamin D (25(OH)D). The second 
reaction takes place in the kidney and is mediated by 1α-hydroxylase which converts 25(OH)D 
to the biologically active hormone named calcitriol. Calcitriol is also named 1, 25-
dihydroxyvitamin D. 25(OH)D is the precursor of calcitriol and is also the major circulating 
form of vitamin D. Calcitriol circulates bound to a plasma carrier fibroblast protein called 
vitamin D binding protein (vit. DBP) (Institute of Medicine, 2011).  
Renal synthesis of calcitriol is regulated tightly by two counteracting hormones, there is 
up-regulation through the parathyroid hormone (PTH) and down-regulation through fibroblast-
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like growth factor-23 (FGF23). When there are low levels of serum phosphorus, calcitriol 
synthesis is stimulated. When there are high serum phosphorus levels calcitriol synthesis is 
inhibited. Once calcitriol is synthesized in the kidney, it binds to VDBP to be transported to 
target organs.  
Vitamin D by itself is inactive, but the actions that vitamin D has on our bodies are 
because of the active metabolite, calcitriol. Calcitriol acts on the development and maintenance 
of bone health. Vitamin D Receptors (vit. DRs) are found throughout the body in tissues that are 
not involved with calcium and phosphate homeostasis. vit. DRs having a presence in body 
tissues implies that calcitriol may play a more general role on ligands other than calcitriol that 
can activate the vit. DR. Vitamin D-responsive elements (vit. DREs) are considered the hallmark 
of vit. D action. vit. DREs are present in many human genes that are involved in a wide range of 
classical and non-classical roles that include regulation of cell proliferation, cell differentiation, 
and apoptosis (Institute of Medicine, 2011). Throughout this paper serum 25(OH)D levels were 
addressed in ng/ml for consistency.  
The IOM and most research on vit. D use serum concentrations of 25(OH)D as a measure 
of vit. D, as previously mentioned, because it reflects both intake from diet and cutaneous 
synthesis (Alshahrani & Aljohani, 2013), (Institute of Medicine, 2011). The IOM expresses vit. 
D quantities as International Units (IU). Vitamin D is also expressed as micrograms (μg) for 
which 1 μg is equal to 40 IU. The serum concentrations of 25(OH)D are expressed as nanomoles 
per liter (nmol/l) or another way to express this is nanograms per milliliter (ng/ml). If needed, the 
values that are expressed as nmol/l are divided by the conversation factor of 2.5 to obtain an 
equivalent measure in ng/ml (Institute of Medicine, 2011).  
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Vitamin D Recommendation by Institute of Medicine 
When assessing vit. D requirements, the IOM considered what type of effects vit. D 
deficiency could lead to, e.g. alteration in bone health as evidenced by rickets in children and 
osteomalacia in adults. The main circulating form of vit. D is 25(OH)D and serum 25(OH)D 
concentrations are currently thought as the gold standard of measuring vit. D status. There is 
currently a lack of clarity on the impact several variables have on serum concentrations of 
25(OH)D. The IOM recognized that serum 25(OH)D concentrations can reflect intake as it 
relates to bone health outcomes. Serum 25(OH)D concentrations have a dose-response 
relationship and is based under the impression that there is minimal sun exposure (Institute of 
Medicine, 2011).  
 The IOM committee made conclusions about serum 25(OH)D concentrations in 
relationship to the DRI development. The DRI was established based on conclusions that 
include, bone health specifically with calcium absorption, rickets, serum 25(OH)D level, fracture 
risk and osteomalacia (Institute of Medicine, 2011). A serum 25(OH)D concentration below 12 
ng/ml is associated with increased risk of rickets, impaired fractional calcium absorption, 
decreased bone mineral content in children and adolescents, increased risk of osteomalacia; 
impaired fractional calcium absorption and increased risk of osteomalacia in young and middle-
aged adults; and impaired fractional calcium absorption and fracture risk in older adults. The 
IOM committee concluded that serum 25(OH)D concentrations above 20 ng/ml did not have any 
additional benefit to any of the above indicators of bone health. Serum 25(OH)D concentration 
of 20 ng/ml is considered an adequate value to cover the needs of 97.5 percent of the population 
according to the IOM. The median requirement of serum 25(OH)D levels was estimated to be 16 
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ng/ml. A serum 25(OH)D value between 12 and 20 ng/ml for all age groups is an appropriate 
range of vit. D level per the IOM.  
 Specifications of vit. D among the DRI for adequacy were then established for each age 
group. The data gathered from the IOM committee were not sufficient to establish an EAR for 
infants under the age of 1 year so an AI was developed. There was not enough data to establish a 
DRI because the content of human milk does not shed light on the requirements of vit. D in 
infants, as breast milk is generally not a substantial source of vit. D. The AI for infants 0-6 
months and 6-12 months was set at 400 IU of vit. D. The IOM committee found no data with 
clinical deficiency among infants who received daily intakes of 400 IU of vit. D. For children 
and adolescents 1-18 years of age, there was a focus for normal, healthy bone and is the basis for 
these DRI values. The EAR was set at 400 IU of vit. D and the RDA was set at 600 IU of vit. D 
(Institute of Medicine, 2011)(Table 1).    
For adults 19-50 years of age, bone density maintenance was a focus when setting the 
EAR and RDA. Serum 25(OH)D concentrations regarding calcium absorption was the basis of 
establishing the DRI for vit. D in these adults. The IOM committee concluded that calcium 
absorption is maximal at serum 25(OH)D concentrations between 12-20 ng/ml and no increase 
of calcium absorption was noted above 20 ng/ml. Again, 400 IU daily was set as the EAR and an 
RDA of 600 IU daily was established for adults 19-50 years old (Institute of Medicine, 2011). 
Dietary reference intake for adults 51-70 years old and those greater than the age of 70 
was set on the ability to maintain bone density and decrease the level of bone loss. Fracture risk 
was also a central theme examined for establishing the DRI in this age group because those 
greater than 70 years of age are at a higher risk of mortality and morbidity associated with 
fractures. For adults 51-70 years old, other factors were considered in establishing the DRI that 
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affect daily requirements of vit. D. Impaired renal function, less efficient synthesis of vit. D in 
the skin, lower endogenous production of the active form of vit. D, increased PTH and age-
related changes in body composition such as loss of muscle volume or muscle mass can affect 
daily requirements of vit. D. Institutionalization is also mentioned by the IOM committee that 
can affect the need for vit. D among this age group. An EAR of 400 IU daily and an RDA of 800 
IU daily were set for this life stage group again, assuming minimal sun exposure (Table 2) 
(Institute of Medicine, 2011). 
Vitamin D requirements during pregnancy and lactation were examined and based on 
AHRQ-Ottawa’s findings and randomized control trials (Institute of Medicine, 2011). For both 
groups, an EAR of 400 IU and RDA of 600 IU daily were set (Institute of Medicine, 2011). 
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Table 2 
Dietary Reference Intakes for Vitamin D for Individuals across the Lifespan 
Life Stage Group Estimated Average 
Requirement (IU/day) 
Recommended Dietary 
Allowance (IU/day) 
Upper Level 
Intake (IU/day) 
Infants 0 to 6 months * * 1,000 
Infants 6 to 12 months * * 1,500 
1-3 years old 400 600 2,500 
4-8 years old 400 600 3,000 
9-13 years old 400 600 4,000 
14-18 years old 400 600 4,000 
19-30 years old 400 600 4,000 
31-50 years old 400 600 4,000 
51-70 years old 400 600 4,000 
>70 400 800 4,000 
14-18 years old, 
pregnant/lactating 
400 600 4,000 
19-50 years old, 
pregnant/lactating 
400 600 4,000 
*For infants, Adequate Intake (AI) is 400 IU/day for 0 to 6 months of age and 400 IU/day for 6 
to 12 months of age (Institute of Medicine, 2011) 
Sources of Vitamin D 
 Sources of vit. D include sun exposure, food and dietary supplements. Few foods are 
natural sources of vit. D; such as fatty fish, fish liver oil and egg yolk. Other foods are fortified 
with vit. D, e.g. fluid milk in the United States. Other foods that are now being fortified with vit. 
D include ready-to-eat breakfast cereals, some milk substitutes, yogurts, cheeses, juices and 
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spreads in the U.S.; vit. D2 and vit. D3 are both used for fortification (Institute of Medicine, 
2011).  
 Vitamin D is also synthesized in the skin from 7-dehydrocholesterol following sun 
exposure to ultraviolet B (UVB) radiation. The conversion of 7-dehydrocholesterol to the 
previtamin D3 depends on the amount of UVB radiation that reaches the dermis and availability 
of 7-dehydrocholesterol. Factors associated with the amount of vit. D that is synthesized from the 
skin depend on season of the year, skin pigmentation, latitude, use of sunscreen, clothing, 
adiposity, size (i.e. obesity) and frequency of dose and amount of skin that is exposed. Other 
factors include decline in vit. D synthesis with increasing age due to decrease in 7-
dehydrocholesterol concentrations and to some extent because of alterations that occur in skin 
morphology. vit. D toxicity from the sun cannot occur, but toxicity from supplementing with vit. 
D is possible (Institute of Medicine, 2011). The first reports of hypervitaminosis D were around 
1928-1932, consequences were hypercalcemia and soft tissue calcification that resulted in renal 
and cardiovascular damage (Institute of Medicine, 2011). Holick et al. (2011) stated that when an 
adult wearing a bathing suit is exposed to one minimal erythemal dose of UV radiation, which is 
when the skin has a slight pinkness to it 24 hours after sun exposure, this is equivalent to 
ingesting between 10,000 and 25,000 IU of vit. D in supplements. It is also noted that the vit. D 
that is produced in the skin potentially lasts twice as long in the blood compared to vit. D that is 
ingested (Holick, et al., 2011). 
 Vitamin D is a fat-soluble vitamin and is most efficiently absorbed with other dietary fats 
in the small intestine which also is dependent upon the presence of fat in the lumen. The optimal 
amount of fat needed for maximal absorption of vit. D has not yet been determined. If one does 
not have an adequate amount of bile or has pancreatic insufficiency this can reduce the 
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absorption of vit. D significantly (Institute of Medicine, 2011). There are very few foods that 
naturally contain vit. D2 or vit. D3 (Table 3).  
 Dawson-Hughes et al. (2015) tested the hypotheses that absorption of vit. D3 is greater 
when the supplement is taken alongside a meal that contains fat compared to one that was fat-
free (Dawson-Hughes, et al., 2015). Also looking at if absorption is greater when the fat type in 
the meal is higher in monounsaturated-to-polyunsaturated fatty acid ratio (MUFA: PUFA). 
Researchers examined and open, three-group, single dose vit. D3 comparative absorption 
experiment. Participants consisted of 50 healthy older men and women randomly assigned to one 
of the three meal groups; fat-free meal, a meal with 30% of calories as fat with a low (1:4) and 
one with a high (4:1) MUFA: PUFA ratio (Dawson-Hughes, et al., 2015). Participants fasted for 
12 hours and then all subjects took a single 50,000 IU dose of vit. D3 with their breakfast meal. 
Plasma vit. D3 levels were measured before, at 10, 12 and 14 hours after the dose. Plasma vit. 
D3 levels at mean peak (12-hours) was 32% greater in participants who consumed the fat-
containing meal compared to the fat-free meal. The absorption did not differ significantly at any 
point in the high and low MUFA and PUFA groups (Dawson-Hughes, et al., 2015). Researchers 
concluded that when fat is present at a meal in which a vit. D3 supplement is taken significantly 
enhances absorption of the supplement. The amount of MUFA vs. PUFA contained in the meal 
does not influence absorption (Dawson-Hughes, et al., 2015). 
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Table 3 
Natural Sources of Vitamin D2 and Vitamin D3 
Source Vitamin D content 
Cod liver oil 400-1,000 IU/teaspoon vit. D3 
Salmon, fresh wild 
caught 
600-1,000 IU/3.5 oz vit. D3 
Salmon, fresh 
farmed 
100-250 IU/3.5 oz vit. D3, vit. D2 
Salmon, canned 300-600 IU/3.5 oz vit. D3 
Sardines, canned 300 IU/3.5 oz vit. D3 
Mackerel, canned 250 IU/3.5 oz vit. D3 
Tuna, canned 236 IU/3.5 oz vit. D3 
Shiitake 
mushrooms, fresh 
100 IU/3.5 oz vit. D2 
Shiitake 
mushrooms, sun-
dried 
1,600 IU/3.5 oz vit. D2 
Egg yolk 20 IU/yolk vit. D3 or D2 
Sunlight/UVB 
radiation 
20,000 IU equivalent to sun exposure to 1 minimal erythemal dose in a 
bathing suit. Exposing arms and legs to 0.5 minimal erythemal dose is 
equivalent to consuming 3,000 IU vit. D3. 
 (Holick, et al., 2011) 
 The United States and Canada fortify milk with vit. D along with some bread products, 
orange juices, cereals, yogurts and cheese. In Europe, most countries do not fortify milk with vit. 
D because of a law that forbids the fortification of foods with vit. D. Some European countries 
are fortifying cereals, breads and margarine with vit. D. Multivitamin supplements in the United 
States contain 400-1,000 IU of vit. D2 or vit. D3 and vit. D3 supplements contain anywhere from 
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400-50,000 IU of vit. D3. Pharmaceutical sources in the United States only contain vit. D2 as 
50,000 IU capsules or as a liquid with 8,000 IU (Table 4) (Holick, et al., 2011). 
Table 4 
Fortified Foods, Pharmaceutical Sources and Supplemental Sources of Vitamin D2 and Vitamin 
D3 
Source Vitamin D Content 
Fortified Foods  
Fortified milk  100 IU/8 oz, usually vit. D3 
Fortified orange juice 100 IU/8 oz vit. D3 
Infant formulas 100 IU/8 oz vit. D3 
Fortified yogurts 100 IU/8 oz, usually vit. D3 
Fortified butter 56 IU/3.5 oz, usually vit. D3 
Fortified margarine 429 IU/3.5 oz, usually vit. D3 
Fortified cheeses 100 IU/3 oz, usually vit. D3 
Fortified breakfast cereals 100 IU/serving, usually vit. D3 
Pharmaceutical sources in the United 
States 
 
vit. D2 (ergocalciferol) 50,000 IU/capsule 
Drisdol (vit. D2) liquid 8,000 IU/ml 
Supplemental Sources  
Multivitamin 400, 500, 1,000 IU vit. D3 or vit. D2 
vit. D3 400, 800, 1,000, 2,000, 5,000, 10,000 and 50,000 
IU 
(Holick, et al., 2011) 
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Sun Exposure and Vitamin D 
 Factors that the IOM considered in the estimation of DRI for vit. D include sun exposure 
and vit. D synthesis. Other aspects considered were public health recommendations that regard 
the need to limit sun exposure to avoid cancer risk. The IOM committee also assumed that 
entities who are going to use the DRI values for health policy or public health applications would 
adjust their considerations in relation to adequacy of the diet based on if the population of 
interest is minimally, moderately, or highly exposed to sunlight (Institute of Medicine, 2011). 
 Toxicity of vit. D cannot occur during prolonged periods of UV radiation exposure. 
There is a steady state reached in which 10-15% of cutaneous 7-dehydrocholesterol is converted 
to previtamin D3 (Tsiaras & Weinstock, 2011).  It is suggested that this process of 
photoregulation ensures that toxic levels of vit. D3 are not synthesized under condition of 
excessive sun exposure (Tsiaras & Weinstock, 2011). When vit. D is synthesized cutaneously, it 
is then released from the plasma membrane and enters the systemic circulation bound to vit. 
DPB. Serum concentrations of vit. D3 peaks at 24-48 hours after UV radiation exposure. vit. D3 
serum half-life ranges from 36-78 hours. Vitamin D3 can also be taken up by adipocytes and 
stored in subcutaneous or omental fat deposits for later use (Tsiaras & Weinstock, 2011). This 
distribution of vit. D3 into adipose tissue prolongs the total-body half-life to about two months 
(Tsiaras & Weinstock, 2011). Factors that affect cutaneous synthesis of vit. D include exposure 
to ultraviolet radiation. Processes that alter the amount of UVB radiation entering the skin can 
affect vit. D3 production. UVB radiation is the portion of electromagnetic spectrum between 280 
nm and 320 nm. Optimum wavelengths for production of vit. D3 are between 295 nm and 300 
nm with peak production at 297 nm (Tsiaras & Weinstock, 2011). The amount of UVB radiation 
that can reach the earth’s surface is influenced by many factors. Those factors include the ozone, 
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substances UVB must travel through such as oxygen, nitrogen, aerosols, water vapor, particulate 
pollutants and cloud matter (Tsiaras & Weinstock, 2011). The time of year, time of day and 
latitude also affect UVB radiation. UBV radiation reaches a maximum at mid-day in the summer 
months, with latitudes below 35˚ North having sufficient UVB radiation for vit. D3 production 
all year long (Tsiaras & Weinstock, 2011). At higher latitudes vit. D3 cannot be produced in the 
winter months. At a latitude of 41.9˚ North, Rome, Italy has no cutaneous synthesis of vit. D3 
from November through February. When going ten degrees further North at a latitude of 52.5˚ 
North Berlin, Germany, one cannot produce cutaneous synthesis of vit. D3 from October to April 
(Tsiaras & Weinstock, 2011). The latitude of Fargo, ND is 46.9˚ North (Longitude, 2016). 
 Sun protection is recommended for skin cancer prevention; hence, Linos et al. (2012) 
examined the relationship between different types of sun protective behaviors and serum 
25(OH)D concentrations in the general US population (Linos, et al., 2012). This cross-sectional 
study collected data from 5,920 adults aged 18-60 years old. Individuals provided data as part of 
the 2003-2006 US National Health and Nutrition Examination Survey (NHANES). Sun 
protective behaviors were analyzed. The primary outcomes were serum 25(OH)D concentrations 
and vit. D deficiency. Vitamin D deficiency was defined as 25(OH)D concentrations <20 ng/ml. 
Staying in the shade and wearing long sleeves were significantly associated with lower 25(OH)D 
concentrations. The associations were most significant for whites compared to Hispanics or 
blacks. White participants who reported that they frequently stayed in the shade or wore long 
sleeves had double the odds of vit. D deficiency compared with those who rarely did so. 
Frequent sunscreen use and wearing a hat did not have an impact on 25(OH)D concentrations or 
vit. D deficiency (Linos, et al., 2012).  
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 One randomized controlled trial examined UVB radiation and how it increases serum vit. 
D levels, expressed as 25-hydroxyvitamin D₃ (25(OH)D3) in a dose-response relationship (Bogh, 
Schmedes, Philipsen, Thieden, & Wulf, 2010). Researchers examined 172 fair-skinned persons. 
Participants were screened for 25(OH)D3 levels and then selected and randomized into one of 
eleven groups with five participants in each group. Each of the groups was exposed to one of 
four different UVB doses for 1, 5, 10 or 20 minutes. The study participants had four different 
UVB sessions with a 2-3-day interval between and 24% of their skin exposed. The skin 
pigmentation and 25(OH)D3 levels were measured before and after UVB exposure. The increase 
in 25(OH)D3 levels after exposure was positively correlated with the UVB dose but not to the 
dose rate (1-20 minutes). Researchers found that the increase in 25(OH)D3 levels after UVB 
exposure was achieved with very low UVB doses which was around 4 minutes at noon time in 
the summer (Bogh, Schmedes, Philipsen, Thieden, & Wulf, 2010).  
 The American Academy of Dermatology (AAD) points out in their position statement on 
vit. D that there is no scientifically validated safe threshold of UV exposure from the sun or 
indoor tanning devices that will allow for max vit. D synthesis without increasing skin cancer 
risk. The Academy further recommend the use of a comprehensive photo protective regimen that 
includes the regular use and proper use of broad-spectrum sunscreen. The AAD also summarizes 
the current IOM recommendations and DRI for vit. D, pointing out specifically that the RDA 
was derived based on minimal or no sun exposure. In conclusion, the AAD states that vit. D 
should be obtained from a healthy diet that includes foods naturally rich in vit. D, 
foods/beverages fortified with vit. D, and/or vit. D supplements and that vit. D should not be 
obtained from unprotected exposure to ultraviolet radiation (AAD, 2010). 
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 Since cutaneous synthesis is an important source of vitamin D, another study by Farrar et 
al. (2013) examined the efficacy of a dose range of simulated summer sunlight exposures in 
raising vitamin D status among UK adults of South Asian ethnicity (Farrar, et al., 2013). This 
was a dose-response study among 60 healthy adults of South Asian ethnicity, 20-60 years old. 
Participants received 1 of 6 ultraviolet exposures that were equivalent to 15-90 minutes of 
unshaded noontime summer sunlight at 53.5 degrees north. The ultraviolet exposure was 3 times 
per week for 6 weeks while wearing casual clothes that revealed about 35% skin area. Serum 
25(OH)D concentrations were measured weekly and dietary vitamin D intake was estimated. 
Most participants (n=51) at baseline were vit. D insufficient with serum 25(OH)D concentrations 
<20 ng/ml (Farrar, et al., 2013). All participants had a significant increase in 25(OH)D 
concentrations. This study gives insight to how sunlight exposure can usefully enhance vitamin 
D status to avoid deficiency. Optimal sun exposure was found to be equivalent to 45 minutes of 
unshaded noontime exposure 3 times weekly with 35% of skin surface area exposed among 
people of South Asian ethnicity to prevent vit. D deficiency and reach a vit. D status >10 ng/ml 
(Farrar, et al., 2013). 
Casual exposure to sunlight is generally thought to provide enough sun exposure for vit. 
D requirements. Webb et al. (2010) examined if personal sunlight exposure levels could provide 
vit. D sufficiency, defined as serum 25(OH)D concentrations of ≥20 ng/ml and optimal levels, 
defined as serum 25(OH)D concentrations of >32 ng/ml among the U.K. public in a prospective 
cohort study (Webb, et al., 2010). Researchers measured circulating 25(OH)D concentrations 
monthly for 12 months in 109 white adults aged 20-60 years old in Greater Manchester. Intake of 
vitamin D through the diet and through personal ultraviolet radiation exposure were assessed 
over 1-2 weeks in each season of the year. Their primary analysis was to determine the post-
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summer peak of 25(OH)D concentrations that are required to maintain vit. D sufficiency in 
wintertime. They found that intake through the diet remained low all year long through each 
season and personal ultraviolet radiation exposure levels were high in spring and summer, low in 
autumn and negligible in the winter season (Webb, et al., 2010). Their results also found that 
mean 25(OH)D concentrations were highest in September and lowest in February. Ultimately, 
they concluded that late summer 25(OH)D concentrations that approximate the optimal range are 
required to retain sufficiency throughout the U.K. winter. Much of the population failed to reach 
this post-summer level and became vitamin D insufficient during the winter. This indicates that 
the population requires more guidance in how to maintain vitamin D status more effectively and 
that public health policies on skin cancer need to take into consideration vitamin D requirements 
(Webb, et al., 2010).  
Keumala et al. (2014) showed that vit. D deficiency can occur in women living in a 
tropical country who are likely exposed to more sun than women living in non-tropical countries 
(Keumala, Alrasyid, NurIndrawaty, & Zulkifli, 2014). This cross-sectional study was conducted 
on 156 healthy women during the dry season in North Sumatera. The study found that vit. D 
deficiency did exist among women in a tropical country and especially in those with less than 1 
hour a day of sun ray exposure, having indoor occupations, inadequate intake of vit. D and those 
with low physical activity levels (Keumala, Alrasyid, NurIndrawaty, & Zulkifli, 2014). Also of 
interest only 5% of the studied population had sufficient vit. D levels defined as serum 25(OH)D 
concentrations 32-100 ng/ml. Ninety-five percent of participants were vit. D deficient, defined as 
serum 25(OH)D concentrations <20 ng/ml and insufficient, defined as serum 25(OH)D 
concentrations 20-32 ng/ml (Keumala, Alrasyid, NurIndrawaty, & Zulkifli, 2014).  
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Vitamin D Storage 
 In 1971 Rosenstreich et al. (1971) first showed that adipose tissue was the primary site of 
accumulation of vit. D. Vitamin D was radiolabeled in all body tissues by supplementing rats 
that were completely vit. D deficient with oral vit. D3 for 2 weeks. Rats were protected from 
sunlight by hanging cages in complete darkness. After supplementation, all vit. D was withheld 
and radioactivity and vit. D content in organs and tissues of rats was measured. Adipose tissue 
contained the greatest quantity of radioactivity throughout the 3-month experiment with the 
slowest rate of release. The researchers concluded that adipose tissue is the major storage site for 
vit. D3 in the absence of sunlight (Rosenstreich, Rich, & Volwiler, Deposition in and release of 
vitamin D3 from body fat: evidence for a storage site in the rat, 1971).  
Wortsman et al’s (2000) study showed that in obese subjects, vit. D was stored in adipose 
tissue and not released when it was needed (Wortsman, Matsuoka, Chen, Lu, & Holick, 2000). 
This suggests that obese individuals likely require a larger amount of vit. D to achieve a serum 
25(OH)D level that is similar to someone who is of normal weight. They concluded that obesity 
associated vit. D insufficiency is due to the decreased bioavailability of vit. D3 from cutaneous 
and dietary sources because of its deposition in body fat compartments (Wortsman, Matsuoka, 
Chen, Lu, & Holick, 2000).  
Optimum Serum Levels of Vitamin D   
Serum 25(OH)D is the major circulating form of vit. D. The half-life of vit. D is 2-3 
weeks and is currently the best indicator to monitor vit. D status. Vitamin D adequacy, 
deficiency and insufficiency can be defined in different ways. This paper uses the Endocrine 
Society’s recommendations to outline what serum 25(OH)D level is considered adequate, 
deficient or insufficient (Holick, et al., 2011). Vitamin D deficiency is defined as 25(OH)D 
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levels ≤20 ng/ml, vit. D insufficiency as 25(OH)D of 21-29 ng/ml. Adequacy is defined as serum 
25(OH)D levels ≥30 ng/ml (Holick, et al., 2011). The IOM suggests that 20 ng/ml is an adequate 
vit. D level for the general population. This varies when considering different age groups; for 
example, children and adolescents 1-18 years of age, 16 and 20 ng/ml are considered adequate 
respectively.  
Some studies suggested that for optimal calcium absorption vit. D concentrations need to 
be about 34 ng/ml, and for neuromuscular performance it is thought that vit. D concentrations 
need to be about 38 ng/ml (Alshahrani & Aljohani, 2013). Most experts collectively believe that 
30 ng/ml is considered adequate (Alshahrani & Aljohani, 2013). Others still recommend a lower 
limit of 40 ng/ml due to the possibility of impaired calcium metabolism at this level. Clearly 
there is debate over what concentration is optimal for vit. D (Alshahrani & Aljohani 2013).  
Vitamin D Deficiency and Impact on Pregnancy  
 One cause of vit. D deficiency among children and adults is inadequate sunlight 
exposure. The use of sunscreen with sun protection factor of 30 can reduce vit. D synthesis by 
the skin more than 95% and people who have naturally darker skin tone have an even more 
natural sun protection. Those with naturally darker skin tone might need three to five times 
longer exposure to sunlight to make the same amount of vit. D compared to a person with a 
white skin tone (Holick, et al., 2011). Another risk factor of vit. D deficiency is obesity. Ekwaru 
et al. (2014) found that vit. D supplementation might need to be 2-3 times higher for obese 
individuals (BMI <30 kg/m²) and 1.5 times higher for overweight individuals (BMI >25 kg/m² 
and ≤30 kg/m²) compared to normal weight individuals (BMI >18.5 kg/m² and ≤25 kg/m²) 
(Ekwaru, Zwicker, Holick, Giovannucci, & Veugelers, 2014). Individuals who are obese are at 
an increased risk for vit. D deficiency because body fat sequesters the fat-soluble vitamin 
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(Holick, et al., 2011). There are other medical diagnoses associated with vit. D deficiency such 
as patients with fat malabsorption syndromes like individuals with low bile amounts or 
pancreatic insufficiency with cystic fibrosis and patients that have had bariatric surgery who are 
unable to absorb the fat-soluble vitamins. Patients with nephrotic syndrome lose 25(OH)D 
through the urine due to 25(OH)D being bound to the vit. D-binding protein. Medications, such 
as anticonvulsants, glucocorticoids or AIDS treatments can cause an increased catabolism of 
25(OH)D and 1,25-dihydroxyvitamin D₂ (1,25(OH)₂D) can be at an increased risk of vit. D 
deficiency (Holick, et al., 2011).    
 During the first and second trimesters in pregnancy, the fetus is working on developing 
its organ systems and laying down collagen matrix for its skeleton. In the third trimester, the 
fetus begins to calcify the skeleton which increases the maternal demand for calcium. This 
increased demand for calcium causes an increase in production of 1,25(OH)₂D by the mother’s 
kidneys and placenta. Concentrations of circulating 1,25(OH)₂D increase gradually in the first 
and second trimesters because there is an increase in vit. D binding protein concentrations. Free 
levels of circulating 1,25(OH)₂D are responsible for enhancing intestinal calcium absorption and 
only increase in the third trimester. Pregnant women are at an increased risk for vit. D deficiency 
and consequences can range from preeclampsia to GDM (Holick, et al., 2011).   
 Deficiency of vit. D can result in abnormalities in calcium, phosphorus, and bone 
metabolism and more specifically vit. D deficiency can cause a decrease in the efficiency of 
intestinal calcium and phosphorus absorption of dietary calcium and phosphorus which results in 
an increase in PTH levels (Holick, et al., 2011). Griffiths et al. (2015) examined the effect of 
prenatal vit. D intake on healthcare utilization in the first three years of life (Griffiths, et al., 
2015). Researchers proposed that observational studies have suggested that higher prenatal vit. D 
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intake might be associated with improved health outcomes in childhood, with mixed results. 
There were 180 women at 27 weeks gestation allocated to no vit. D, 800 IU ergocalciferol daily 
until delivery, or a single oral bolus of 200,000 IU cholecalciferol. Supplementation with vit. D 
increased maternal and cord blood 25(OH)D concentrations but the serum levels remained lower 
than current recommendations (Griffiths, et al., 2015). Researchers found no differences in total 
healthcare utilization costs between the control and daily or control and bolus groups. There 
were also no adverse effects of supplementation reported from vit. D supplementation. The vit. D 
doses provided from 27 weeks gestation to delivery failed to completely correct maternal vit. D 
deficiency suggesting a higher dose might be needed (Griffiths, et al., 2015). 
 Cadario et al. (2015) investigated 25(OH)D levels in maternal serum and neonatal blood 
spots among native and migrant populations living in Novara, North Italy which resides at 45˚N 
latitude (Cadario, et al., 2015). Researchers carried out a cross sectional study from April 1, 
2012-March 30, 2013. Maternal blood samples after delivery and newborn blood spots were 
gathered and analyzed for 25(OH)D levels among 533 pairs. Country of origin, skin phototype, 
vit. D dietary intake and supplementation during pregnancy were recorded (Cadario, et al., 
2015). Researchers found a link between neonatal and maternal 25(OH)D levels. Severely 
deficient 25(OH)D levels (<10 ng/ml) were found in 18% of Italian and 48.4% of migrant 
mothers, 38% of Italian and 76.2% of migrant newborns were also severely deficient. Serum 
25(OH)D levels between 10-20 ng/ml which are deficient levels of vit. D were found in 43.6% of 
Italian and 41.3 % of migrant mothers and in 40.1% of Italian and 21.7% of migrant newborns 
(Cadario, et al., 2015). Italian mothers and their newborns had higher 25(OH)D levels than 
migrants and a linear decrease of 25(OH)D levels was found with increasing skin pigmentation. 
While vit. D supplementation resulted in higher 25(OH)D levels both in mothers and their 
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newborns (Cadario, et al., 2015). Researchers concluded that vit. D insufficiency in pregnancy 
and in newborns is frequent, especially among migrants. Researchers also urge there to be a 
prevention program so people identified as being at risk can be closely monitored and believe 
that vit. D supplementation should be thought out when considering a preventative health care 
policy (Cadario, et al., 2015).  
 Barati et al. (2016) aimed to evaluate the serum levels of vit. D among pregnant women 
at their first prenatal visit during their first trimester between February 2014 and February 2015 
(Barati, Zarei, Moramezi, Saadati, & Masihi, 2016). Age, weight, BMI and gravid were recorded 
among 126 participants. Serum 25(OH)D levels and fasting blood sugar were checked, history of 
diabetes mellitus was also obtained. Blood levels of 25(OH)D ≤8 ng/ml were diagnosed as 
deficiency, 8-12 ng/ml as insufficiency and >12 ng/ml as normal. There were 85 participants 
found to have deficiency, 27 participants had insufficiency and 14 participants had normal vit. D 
levels. Among those who were overweight about 70.5% had low vit. D levels and in obese 
persons 64.3% had vit. D deficiency (Barati, Zarei, Moramezi, Saadati, & Masihi, 2016). All low 
weight persons suffered from vit. D deficiency. Despite an intense and sunny climate in almost 
all seasons in Pakistan, vit. D deficiency can be found in abundance. Researchers’ 
recommendations are to measure levels of vit. D in the first trimester of pregnancy in all 
pregnant women (Barati, Zarei, Moramezi, Saadati, & Masihi, 2016).  
 De Laine et al. (2013) evaluated the vit. D status of pregnant women to assess the 
sensitivity of the current risk-based screening guidelines (De Laine, Matthews, & Grivell, 2013). 
Researchers conducted a prospective audit of vit. D levels of all women that presented for their 
first antenatal visit for three, four-week periods between 2009-2010 in South Australia (De 
Laine, Matthews, & Grivell, 2013). Levels of 25(OH)D3 were measured along with participants’ 
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BMI, self-reported ethnicity and whether vit. D testing was indicated based on the hospital 
guidelines. Hospital guidelines included ‘high-risk’ groups who were veiled, dark-skinned and 
house-bound women, per the South Australian Perinatal Practice Guidelines (De Laine, 
Matthews, & Grivell, 2013). Participants consisted of 472 women, 67.4% were considered ‘low-
risk’ for vit. D screening. Of these women, 46.2% and 78.6% of ‘high-risk’ women were vit. D 
deficient with levels <24 ng/ml. About 54.9% of women who were vit. D deficient were 
classified as ‘low-risk’ (De Laine, Matthews, & Grivell, 2013). Researchers found that risk-
based screening criteria for vit. D deficiency failed to detect over half of vit. D deficient women 
at their institution. Researchers also agree that guidelines should include universal screening of 
vit. D for all pregnant women (De Laine, Matthews, & Grivell, 2013). 
 Xiao et al. (2015) aimed to evaluate the vit. D status of women in Eastern China during 
the second trimester of pregnancy (Xiao, et al., 2015). A cross-sectional observational study was 
conducted in a hospital in Wuxi, China (latitude 31.5˚N) where serum 25(OH)D concentrations 
were measured from 5,823 pregnant women from January 2011 to June 2012 (Xiao, et al., 2015). 
Vitamin D deficiency, 25(OH)D levels <12 ng/ml or inadequacy, 25(OH)D levels 12-20 ng/ml 
were identified in 40.7% and 38% of participants, respectively. There were only 0.9% of 
participants that had levels ≥32 ng/ml which is the level recommended as adequate by the 
Endocrine Society (Xiao, et al., 2015). Researchers found that younger women were more likely 
to be deficient in vit. D and there were significant differences in 25(OH)D levels according to 
season (Xiao, et al., 2015). In September 25(OH)D levels reached their peak values and 
fluctuated with average monthly air temperatures. Researchers ultimately found that there is a 
high prevalence of vit. D deficiency among pregnant Chinese women and that 25(OH)D levels 
varied according to season and air temperatures. Researchers also identify a large gap between 
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the levels of vit. D detected in pregnant Chinese women and the levels recommended by the 
Endocrine Society (Xiao, et al., 2015).  
 Pratumvinit et al. (2015) determined vit. D status among pregnant women and examined 
the factors that are associated with vit. D deficiency (Pratumvinit, et al., 2015). Researchers 
conducted a cross-sectional study of 147 pregnant Thai women between 18-45 years old in 
Bangkok, Thailand. Plasma levels of 25(OH)D, intact parathyroid hormone, calcium, albumin, 
phosphate and magnesium were obtained in pregnant women at delivery (Pratumvinit, et al., 
2015). Hypovitaminosis D was defined as 25(OH)D levels <30 ng/ml which 75.5% of pregnant 
women had at delivery. Of the 75.5% of women with hypovitaminosis D 41.5% had vit. D 
insufficiency, defined as 25(OH)D of 20-30 ng/ml, and 34% were found to have vit. D 
deficiency, defined as 25(OH)D <20 ng/ml (Pratumvinit, et al., 2015). Researchers found that 
vit. D deficiency is common among pregnant Thai women. The prevalence of vit. D deficiency 
also increased in women who had a lower pre-pregnancy BMI and who’s 25(OH)D levels were 
collected in the winter. Researchers suggested that vit. D supplementation may be needed as 
routine antenatal care (Pratumvinit, et al., 2015).  
 Lundqvist et al. (2016) studied longitudinally vit. D status during pregnancy and 
postpartum to identify the factors associated with vit. D status in pregnant women in Northern 
Sweden (Lundqvist, Sandstrom, Stenlund, Johansson, & Hultdin, 2016). There were 184 
participants recruited between September 2006 and March 2009. Blood samples and dietary 
intake were estimated using a food frequency questionnaire and questions on intake of vitamin 
supplements at gestational weeks 12, 21 and 35 as well as 12 and 29 weeks postpartum 
(Lundqvist, Sandstrom, Stenlund, Johansson, & Hultdin, 2016). At least one third of participants 
had 25(OH)D levels <20 ng/ml on at least one sampling occasion. Plasma 25(OH)D levels 
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increased slightly over gestation period and peaked late in pregnancy and levels reverted to 
baseline after birth (Lundqvist, Sandstrom, Stenlund, Johansson, & Hultdin, 2016). Gestational 
and postpartum week, season, dietary intake of vit. D and vitamin supplementation were all 
significantly associated to plasma 25(OH)D levels. Season also influenced concentration patterns 
(Lundqvist, Sandstrom, Stenlund, Johansson, & Hultdin, 2016). 
 Rodriguez et al. (2016) assessed the prevalence and determinants of vit. D insufficiency 
and deficiency in pregnant women in Spain (Rodriguez, et al., 2016). Serum 25(OH)D3 levels 
were measured at the first trimester of gestation in 2,036 women from different geographical 
areas of Spain where the latitude ranges from 39-42˚ N. Insufficiency was defined as levels 
between 20-30 ng/ml and deficiency was defined as <20 ng/ml (Rodriguez, et al., 2016). 
Researchers found that 31% and 18% of women were vit. D insufficient and deficient, 
respectively. Independent determinants of 25(OH)D3 levels were season at collection, latitude, 
age, social class, tobacco smoking, physical activity and use of vit. D supplements (Rodriguez, et 
al., 2016). Summer season, Southern latitude, use of vit. D supplements, strong physical activity 
was associated with lower risk of vit. D insufficiency and deficiency. Researchers found a higher 
risk of vit. D deficiency in lower social class and those who smoke. Researchers concluded that 
vit. D insufficiency and deficiency are highly prevalent during pregnancy. Researchers also 
believed that recommendations and policies to detect and prevent low levels of vit. D during 
pregnancy should be developed (Rodriguez, et al., 2016).  
 Bergstrom et al. (2014) examined the prevalence of vit. D insufficiency in pregnant 
immigrant women by assessing 25(OH)D levels, parathyroid hormone and alkaline phosphatase 
as well as the correlation to musculoskeletal pain (Bergstrom, palmer, Persson, & Blanck, 2014). 
Participants consisted of 68 pregnant immigrant women and 51 native Swedish pregnant women 
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who served as controls. Levels of 25(OH)D, parathyroid hormone, alkaline phosphatase and 
musculoskeletal pain were analyzed in all women at 12 weeks and in the immigrant women at 6-
12 months postpartum (Bergstrom, palmer, Persson, & Blanck, 2014). Among immigrant 
women, 77.9% had levels of 25(OH)D <10 ng/ml compared to only 3.9% in the control group. 
Among the immigrant women, 29.4% had 25(OH)D levels <4.8 ng/ml, none of the controls had 
a level this low. There was no correlation between 25(OH)D levels, parathyroid hormone or 
alkaline phosphatase and pain, but there was a significant negative correlation between changes 
in 25(OH)D and pain from 12 weeks gestation to postpartum (Bergstrom, palmer, Persson, & 
Blanck, 2014). Researchers found that low vit. D levels are prevalent among immigrant women 
who live in Sweden with an indication that pain might be associated with these low vit. D levels 
(Bergstrom, palmer, Persson, & Blanck, 2014). 
 Song et al. (2013) aimed to assess the vit. D status of pregnant women residing in Beijing 
(latitude of 39.9˚ N) in winter months (December 2010-February 2011) and evaluate the impact 
maternal factors have on serum 25(OH)D levels (Song, et al., 2013). Participants were 125 
healthy pregnant women, data were collected regarding pre-pregnancy weight, educational 
status, use of multivitamins and other behavioral factors like duration of computer use, walking 
and sun exposure (Song, et al., 2013). Vitamin D deficiency, defined as 25(OH)D levels <20 
ng/ml, was present among 96.8% of participants. Severe vit. D deficiency, defined as 25(OH)D 
levels <10 ng/ml, was present in 44.8% of participants (Song, et al., 2013). Levels of 25(OH)D 
were lower in women with shorter duration of sun exposure (≤0.5 hours per day) than those with 
longer duration of sun exposure (>0.5 hours per day). Even women who had sun exposure ≥1.5 
hours per day had 25(OH)D concentrations of 12.8±3.6 ng/ml (Song, et al., 2013). Those 
participants who reported taking a multivitamin supplement had significantly higher 25(OH)D 
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levels when compared to non-users (Song, et al., 2013). Researchers concluded that pregnant 
women in Beijing are at very high risk of vit. D deficiency in winter and that duration of sun 
exposure and use of multivitamin were the most important determinants for vit. D status. 
Researchers also suggest that other measures may have to be taken for pregnant women to 
improve their vit. D status during the winter (Song, et al., 2013). 
Luque-Fernandez et al. (2013) evaluated seasonal variation in 25(OH)D levels among 
pregnant women while focusing on patterns and determinants of variation (Luque-Fernandez, et 
al., 2013). Three cohort studies in the US included 2,583 non-Hispanic Black and White women 
who had prenatal 25(OH)D levels determined. Researchers observed a peak for 25(OH)D levels 
in the summer months and a low in the winter. The annual mean concentration of 25(OH)D 
levels for Black women were 19.8 ng/ml, for non-Hispanic White women were 33.0 ng/ml 
(Luque-Fernandez, et al., 2013). Researchers found that non-Hispanic Black women had lower 
average 25(OH)D levels throughout the year and a smaller seasonal variation than non-Hispanic 
White women. Researchers also confirmed that 25(OH)D levels had a seasonal variation over a 
calendar year, this information has the potential to enhance public health interventions targeted 
to improve maternal and perinatal outcomes (Luque-Fernandez, et al., 2013).  
  Zhao et al. (2012) looked at the prevalence and correlations of vit. D deficiency 
(25(OH)D levels<12 ng/ml) and inadequacy (25(OH)D levels <12-20 ng/ml) among US women 
of childbearing age (Zhao, Ford, Tsai, Li, & Croft, 2012). Researchers examined 1,814 female 
participants 20-44 years old in the 2003-2006 NHANES. Vitamin D deficiency and inadequacy 
were examined in participants. After age-adjustments, the prevalence of vit. D deficiency was 
11.1% and 25.7% for vit. D inadequacy. Race/ethnicity other than for non-Hispanic white and 
obesity were associated with increased risks, where dietary supplement use, milk consumption 
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more than once per day and potential sunlight exposure during May-October were associated 
with decreased risks for vit. D deficiency and inadequacy (Zhao, Ford, Tsai, Li, & Croft, 2012). 
Current smokers, history of diabetes and cardiovascular disease were also associated with an 
increased risk for vit. D deficiency. Researchers concluded that among women of childbearing 
age, preconception intervention programs may focus on multiple risk factors for vit. D deficiency 
and inadequacy to help improve their vit. D nutrition (Zhao, Ford, Tsai, Li, & Croft, 2012).  
Halicioglu et al. (2011) measured 25(OH)D3 levels among pregnant women in their last 
trimester and in their infants at delivery to determine the factors associated with maternal serum 
25(OH)D3 concentrations (Halicioglu, et al., 2011). Data were collected between March to May 
2008, 258 healthy pregnant women that were ≥37 weeks gestation were included in the study. 
Other factors examined were the number of pregnancies and births, nutritional status, vitamin 
and mineral support during gestation, educational status, clothing style and the economic level of 
the family (Halicioglu, et al., 2011). Mean 25(OH)D3 concentrations of mothers and their infants 
were 11.5±5.4 ng/ml and 11.5±6.8 ng/ml, respectively. Serum 25(OH)D levels were ≤20 ng/ml 
in 90.3% of mothers and within those with levels ≤20 ng/ml; 50.4% had levels ≤10 ng/ml 
(Halicioglu, et al., 2011). Serum 25(OH)D concentrations strongly correlated to those who had 
uncovered dressing style, sufficient consumption of dairy products and multivitamin use during 
pregnancy. Researchers concluded that despite sunny environments, vit. D deficiency and 
insufficiency are highly prevalent among mothers and their neonates, which is related to lifestyle 
and nutritional status of the mothers. Researchers suggested that a more proactive program be 
implemented for women and their babies regarding vit. D intake and supplementation 
(Halicioglu, et al., 2011).  
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 Of the thirteen studies examined all have shown that vit. D deficiency is prevalent among 
pregnant women. Despite environments that are sunny, there continues to be vit. D deficiency 
among this population. It has been shown that increased vit. D supplement use and increased 
intake of vit. D rich foods decrease vit. D deficiency and inadequacy (Zhao, Ford, Tsai, Li, & 
Croft, 2012). One study finds that use of a multivitamin supplement is significantly associated 
with higher 25(OH)D levels which is beneficial to know since prevalence of deficiency is 
common (Song, et al., 2013). The color of one’s skin and seasonal variation effects serum 
25(OH)D levels and should be considered when screening pregnant women who might be 
deficient.   
 Obesity in Pregnancy and Vitamin D Deficiency 
 Obesity during pregnancy might be associated with reduced placental transfer of 
25(OH)D to the fetus (Josefson, et al., 2016). Obese individuals are also known to have reduced 
bioavailability of 25(OH)D levels (Josefson, et al., 2016). Josefson et al. (2016) examined 
associations between maternal BMI and maternal and cord blood levels of 25(OH)D in full term 
neonates born to a single racial cohort who reside at similar latitudes (Josefson, et al., 2016). 
Secondary objects of the study were to examine the associations between maternal glucose 
tolerance with maternal levels of 25(OH)D and the relationship between cord blood 25(OH)D 
levels and neonatal size. Participants were a part of the Hyperglycemia and Adverse Pregnancy 
Outcomes (HAPO) study. Participants met the following criteria: reside at latitudes between 41˚-
43˚ North, maternal white race and gestational age between 39-41 weeks. There were 360 
participants that had height, weight, and a 75-gram fasting oral glucose tolerance test at 28 weeks 
of gestation. Researchers found that maternal serum 25(OH)D levels were lower by 0.40 ng/ml 
for BMI higher by 1 kg/m² (Josefson, et al., 2016). Fasting plasma glucose, insulin sensitivity 
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and presence of GDM were not associated with maternal serum 25(OH)D levels when adjusting 
for maternal BMI. Cord blood 25(OH)D levels were also lower, by 0.26 ng/ml for maternal BMI 
higher by 1 kg/m². It has been suggested by the researchers that maternal 25(OH)D levels are 
associated with maternal BMI (Josefson, et al., 2016). 
 Another study by Lindsay et al. (2015) examining obese pregnant women aimed to assess 
maternal dietary and lifestyle habits (Lindsay, Heneghan, McNulty, Brennan, & McAuliffe, 
2015). This was a prospective observational study that recruited 100 pregnant women with a 
BMI between 30.0-39.9 kg/m². Dietary intakes were assessed using a three-day food diary and a 
structured lifestyle questionnaire which assessed physical activity levels, smoking, alcohol habits 
and wellbeing (Lindsay, Heneghan, McNulty, Brennan, & McAuliffe, 2015). Researchers found 
that macronutrient intakes among obese pregnant women were not compliant to healthy eating 
guidelines with an inadequate intake of carbohydrate and excess intake of saturated fat. Intakes 
of calcium, iron, folate and vit. D were also poor from diet alone (Lindsay, Heneghan, McNulty, 
Brennan, & McAuliffe, 2015). 
 One study showed an inverse relationship between BMI and maternal serum 25(OH)D 
level showing that as BMI increases, serum 25(OH)D levels decrease  (Josefson, et al., 2016). 
The other study examined found poor intakes of vitamin D among pregnant women who had 
BMIs between 30-39.9 kg/m² (Lindsay, Heneghan, McNulty, Brennan, & McAuliffe, 2015). 
With intake among pregnant women low in vit. D and an inverse relationship between BMI and 
serum 25(OH)D levels being prevalent, better prevention programs should be examined for this 
specific population or closer screening for women who are overweight (BMI ≥25.0-<30 kg/m²), 
obese (≥30.0-<40 kg/m²) or morbidly obese (BMI ≥40 kg/m²).    
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 Preeclampsia in Pregnancy and Vitamin D Deficiency 
 Preeclampsia is a major obstetric complication which is defined as new onset of 
hypertension and proteinuria after 20 weeks of gestation (Alvarez-Fernandez, et al., 2015). 
Alvarez-Fernandez et al. (2015) examined the role of 25(OH)D levels and the soluble fms-like 
tyrosine kinase 1 to placental growth factor ratio in the development of early and late-onset 
preeclampsia and to evaluate the relationship between 25(OH)D (Alvarez-Fernandez, et al., 
2015). The physiopathology of preeclampsia remains unclear but clinical signs and symptoms in 
preeclampsia seem to be the result of endothelial dysfunction. Among pregnant women, the 
placenta plays an important role by producing imbalanced concentrations of angiogenic 
(placental growth factor) and anti-angiogenic factors (soluble fms-like tyrosine kinase 1) which 
enters the maternal circulation causing such endothelial dysfunction (Alvarez-Fernandez, et al., 
2015).  Studies have shown high soluble fms-like tyrosine kinase 1 and low placental growth 
factors among women with preeclampsia. This was retrospective, full-blinded cohort study 
among 257 pregnant women. Women with preeclampsia showed lower 25(OH)D levels (mean 
level of 14 ng/ml) at clinical presentation than women who did not have preeclampsia (mean 
level of 16 ng/ml). Those women with serum 25(OH)D levels <20 ng/ml did experience an 
increased risk of developing late-onset preeclampsia but no association was found for early-onset 
preeclampsia (Alvarez-Fernandez, et al., 2015). Researchers concluded that low vit. D status 
among women with suspected late-onset preeclampsia increase the risk of development of the 
disease (Alvarez-Fernandez, et al., 2015).  
 Ringrose et al. (2011) examined the association between vit. D status and hypertension 
during late pregnancy (Ringrose, et al., 2011). Researchers conducted a case-control study during 
September-October 2008 and January-March 2009 among women who were near term. 
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Preeclampsia was defined as having two or more documented blood pressure readings above 
140/90 mmHg at any time during pregnancy. There were 78 participants that met these criteria 
and 109 controls that had blood pressures below 140/90 mmHg during pregnancy. Serum 
25(OH)D levels were measured in all participants (Ringrose, et al., 2011). During summer 
months, 13% of controls and 29% of the cases had 25(OH)D levels <20 ng/ml. During the winter 
months, these numbers rose to 44% and 49%, respectively with both cases and controls being 
more likely to have vit. D deficiency in the winter months (Ringrose, et al., 2011). Researchers 
noted a negative correlation between BMI and 25(OH)D levels and no difference in mean oral 
daily vit. D intake through diet and supplements. The controls gained less weight during 
pregnancy and there was a negative correlation between the highest blood pressure measured in 
pregnancy and 25(OH)D levels (Ringrose, et al., 2011). Researchers concluded that there is a 
high prevalence of vit. D deficiency in pregnant women in Saskatoon, Saskatchewan (latitude 
52˚ North) and women with low circulating vit. D concentrations are more likely to have 
hypertension (Ringrose, et al., 2011).  
 Mirzakhani et al. (2016) assessed the effect of vit. D supplementation, 4,400 vs 400 IU 
per day, initiated between 10-18 weeks of gestation on the development of preeclampsia 
(Mirzakhani, et al., 2016). Effects of serum 25(OH)D levels on preeclampsia incidence at the 
beginning of the study and in the third trimester were studied (Mirzakhani, et al., 2016). 
Researchers also conducted a nested case-control study of 157 women to examine vit. D-
associated gene expression profiles at 10-18 weeks among 47 participants who developed 
preeclampsia. Eight hundred and sixteen women were randomized and 67 (8.2%) developed 
preeclampsia. Among participants, there were no significant differences between the treatment 
and control groups in the incidence of preeclampsia (Mirzakhani, et al., 2016). Vitamin D levels 
 41 
 
during the third trimester among those in the treatment group amounted to 39±15 ng/ml vs. 
27±11 ng/ml in the placebo group. Preeclampsia happened in 33 women in the treatment group 
compared with 34 women in the placebo group. Vitamin D supplementation did increase 
25(OH)D levels during the third trimester, however no reduction in the rate of preeclampsia was 
seen in the vit. D treatment group compared with that of the placebo group (Mirzakhani, et al., 
2016). Women who had adequate vit. D levels (≥30 ng/ml) in both early and late pregnancy, 
regardless of treatment group, had significantly lower incidences of preeclampsia compared with 
those who had adequate levels at these same time points (Mirzakhani, et al., 2016). 
 Rezavand et al. (2016) compared serum levels of vit. D and interleukin-6 (inflammatory 
factors/cytokines) in healthy pregnant women and among those who had preeclampsia 
(Rezavand, et al., 2016). Researchers conducted a case-control study that was performed on 120 
healthy pregnant women and 120 women who had preeclampsia. Serum 25(OH)D levels and 
interleukin-6 levels were obtained (Rezavand, et al., 2016). There was statistically no significant 
difference between mean vit. D levels in the patients and controls (37.64 ± 29.5 ng/ml and 40.06 
±33.20 ng/ml, respectively). Researchers did find higher serum levels of interleukin-6 among 
patients with preeclampsia compared to the control group. Researchers concluded that 
interleukin-6 levels can be considered risk factors for preeclampsia but more studies with a larger 
sample size are needed to evaluate the association between vit. D levels and risk of preeclampsia 
(Rezavand, et al., 2016).  
 Lechtermann et al. (2014) investigated the influence of season on maternal vit. D status 
and placental vit. D metabolism (Lechtermann, et al., 2014). Both 25(OH)D levels and 
1,25(OH)₂D levels were measured during either the winter or summer months. Among 63 
pregnant women at delivery, 43 were healthy pregnant women and 20 had preeclampsia 
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(Lechtermann, et al., 2014). Among patients with preeclampsia, 25(OH)D levels were lower but 
only varied significantly from the controls during summer months (18.21 ± 17.1 ng/ml vs 49.2 ± 
29.2 ng/ml). Researchers found that maternal 25(OH)D levels produced significant results with 
an effect of season and preeclampsia. Researchers concluded that participants with preeclampsia 
had lower vit. D levels in response to seasonal changes (Lechtermann, et al., 2014). 
 Yu et al. (2013) aimed to determine if maternal serum levels of 25(OH)D during the first 
trimester of pregnancy were altered in cases that develop preeclampsia and if levels are related to 
biochemical and biophysical markers of impaired placental perfusion and function (Yu, Ertl, 
Skyfta, Akolekar, & Nicolaides, 2013). Total serum vit. D levels were obtained among 90 cases 
that developed preeclampsia, 30 required delivery before 34 weeks compared to 1,000 unaffected 
controls (Yu, Ertl, Skyfta, Akolekar, & Nicolaides, 2013). There were no significant differences 
in the median serum vit. D levels. Researchers concluded that among pregnant women who 
developed preeclampsia and those who did not, total serum 25(OH)D levels at 11-13 weeks 
gestation were no different (Yu, Ertl, Skyfta, Akolekar, & Nicolaides, 2013).  
 Of the six studies examined on preeclampsia, three had positive findings relating low 
serum 25(OH)D levels to hypertension or preeclampsia during pregnancy. Women who had 
lower 25(OH)D levels had increased chances of having hypertension in one study and another 
showed that higher levels of vit. D at the beginning pregnancy was associated with a lower risk 
of developing preeclampsia (Ringrose, et al., 2011) (Mirzakhani, et al., 2016). However, 
supplementation initiated early in pregnancy did not decrease the incidence of preeclampsia 
(Mirzakhani, et al., 2016). Season also played a role in 25(OH)D levels among participants with 
preeclampsia (Lechtermann, et al., 2014). These studies address the importance of having 
adequate serum 25(OH)D levels prior to pregnancy to help prevent preeclampsia. Two of the 
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studies examined did not find a correlation between serum 25(OH)D levels and preeclampsia and 
one of these studies citing need for a larger sample size to appropriate evaluate an association 
between vit. D levels and risk preeclampsia. One study had mixed results. It appears that further 
research with larger sample sizes are needed to adequately evaluate the association of vit. D 
levels and preeclampsia.  
 Gestational Diabetes Mellitus in Pregnancy and Vitamin D Deficiency 
 Deficiency of vit. D has been shown to be associated with GDM. Vitamin D induces 
insulin receptor expression through the vit. D receptor, enhancing insulin-dependent glucose 
transport (Liu, et al., 2017). Liu et al. (2017) studied the vit. D nutritional status of pregnant 
women with GDM in middle and late pregnancy and analyzed the different sources of vit. D 
intake (Liu, et al., 2017). Participants consisted of 98 pregnant women with GDM and 
subsequently divided into two groups, those who took a vit. D supplement and the control group. 
Levels of 25(OH)D and sources of vit. D intake and the frequency of food consumed rich in vit. 
D were explored (Liu, et al., 2017). The rate of vit. D deficiency (25(OH)D levels <20 ng/ml) 
was 20.4%. Eighty-four pregnant women took a vit. D supplement with a duration of 2 weeks to 
31 weeks and an average daily dose of 517.5 ± 113.1 IU per day (Liu, et al., 2017). Participants 
who took a vit. D supplement had higher serum 25(OH)D levels than those who did not, the rates 
of deficiency were 17.9% and 35.7%, respectively. Researchers concluded that 20.4% of 
pregnant women with GDM in their middle to late pregnancy were deficient in vit. D though 
their levels were higher than the general population (Liu, et al., 2017).  
 O’Brien et al. (2017) aimed to determine if exposure to winter and low maternal 
25(OH)D levels in early pregnancy were associated with maternal glucose metabolism (O'Brien, 
et al., 2017). Participants consisted of 334 pregnant women in Dublin, Ireland (latitude 51-55˚ 
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North), serum 25(OH)D, fasting glucose, insulin and insulin resistance levels were measured at 
12 weeks of gestation and at 28 weeks of gestation (O'Brien, et al., 2017). The season at the first 
antenatal visit was categorized as extended winter (November-April) or extended summer (May-
October). Participants who attended their first antenatal visit during extended winter had lower 
25(OH)D levels compared to those during extended summer (serum 25(OH)D levels 13.2 ng/ml 
vs. 17.6 ng/ml). When comparing those who attended their first antenatal visit during extended 
summer, extended winter was associated with increased insulin resistance levels in early 
pregnancy among 46.7% of participants and among 53.7% of late pregnancy participants 
(O'Brien, et al., 2017). During early pregnancy 25(OH)D levels <12 ng/ml and extended winter 
were independently associated with high fasting glucose levels in late pregnancy (O'Brien, et al., 
2017). Researchers concluded that women who had their first antenatal visit during extended 
winter were more likely to have raised insulin resistance in early pregnancy which lasted to 28 
weeks and was independent of 25(OH)D levels. It is implied that seasonal variation on insulin 
resistance may not be fully explained by differences in vit. D status, which requires further 
exploration (O'Brien, et al., 2017).  
 Dodds et al. (2016) explored associations between 25(OH)D levels and GDM and also 
determined if there was an interaction between smoking and 25(OH)D (Dodds, et al., 2016). 
Researchers conducted a nested case-control study in Halifax, Nova Scotia and Quebec City, 
Quebec. Women were recruited before 20 weeks of gestation and serum 25(OH)D levels were 
measured. There were 395 GDM cases and 1,925 controls. Controls were frequency matched to 
women with any of the study outcomes by site (Dodds, et al., 2016). Participants who smoked 
during pregnancy and had 25(OH)D levels <12 ng/ml compared to non-smokers with 25(OH)D 
levels ≥20 ng/ml (Dodds, et al., 2016). Researchers concluded that there is an inverse association 
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of vit. D status with GDM risk, especially among women who smoke during pregnancy (Dodds, 
et al., 2016). It is also acknowledged that more research is needed to confirm these findings 
(Dodds, et al., 2016). 
 Arnold et al. (2015) examined associations of vit. D status with GDM (Arnold, et al., 
2015). Researchers conducted a nested case-cohort study with 135 GDM cases and 517 non-
GDM controls, serum 25(OH)D and 25(OH)D3 levels were obtained at about 16 weeks (Arnold, 
et al., 2015). Of the GDM cases, there were lower mean total 25(OH)D (27.3 vs. 29.3 ng/ml) and 
25(OH)D3 levels (23.9 vs. 26.7 ng/ml) compared with women who did not develop GDM 
(Arnold, et al., 2015). Researchers found that overall 25(OH)D3 levels, but not total 25(OH)D 
levels were significantly associated with GDM risk. Researchers also found that a 5 ng/ml 
increase in 25(OH)D3 levels was associated with a 14% decrease in GDM risk (Arnold, et al., 
2015). Participants in the lowest quartile for 25(OH)D3 levels had a twofold higher risk of GDM 
compared to women in the highest quartile. Researchers concluded that vit. D status during 
pregnancy, especially 25(OH)D3, is inversely associated with GDM risk (Arnold, et al., 2015). 
 Researchers examining GDM found mixed results when linking serum 25(OH)D levels 
with GDM. Some studies found both positive and negative correlations. One study found 
prevalence of vit. D deficiency to GDM, but 25(OH)D levels of these women with GDM had 
higher 25(OH)D levels compared to the general population (Liu, et al., 2017). Season again 
played a role in insulin resistance but did not show a relationship to 25(OH)D levels in one study 
(O'Brien, et al., 2017). When evaluating the studies examined in this paper on GDM it appears 
that further research is needed to further evaluate a relationship between vit. D deficiency and 
GDM. 
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 Preterm Birth in Pregnancy and Vitamin D Deficiency 
 One study showed that there is a reduced risk of preterm birth with vit. D 
supplementation (McDonnell, et al., 2017). McDonnell et al. (2017) aimed to determine if the 
reported inverse relationship between maternal 25(OH)D and preterm birth risk. Participants 
consisted of 1,064 pregnant patients between 18-45 years old. Women had 25(OH)D testing at 
their first prenatal visit with follow-up testing and free vit. D supplements of 5,000 IU per 
capsule were offered with a treatment goal ≥40 ng/ml. The overall preterm birth rate was 13% 
among women with a live, singleton birth and at least one 25(OH)D test during pregnancy 
(McDonnell, et al., 2017). Researchers found that women with 25(OH)D levels ≥40 ng/ml had a 
62% lower risk of preterm birth compared to those with 25(OH)D levels <20 ng/ml (McDonnell, 
et al., 2017). Researchers also found that women with initial 25(OH)D levels <40 ng/ml, preterm 
birth rates were 60% lower for those with ≥40 ng/ml vs <40 ng/ml on a follow up test. Overall, 
researchers found that 25(OH)D concentrations ≥40 ng/ml were associated with substantial 
reduction in preterm birth risk (McDonnell, et al., 2017). McDonnell et al. (2017) found a 
positive correlation between serum 25(OH)D concentrations and preterm birth risk. Researchers 
state that vit. D testing and supplementation of pregnant women is a safe and affordable 
prevention tool that could help to substantially reduce the occurrence of preterm birth 
(McDonnell, et al., 2017). 
 Miscarriage in Pregnancy and Vitamin D Deficiency 
Recurrent miscarriage happens in approximately 1-3% in couples of reproductive age, 
with several mechanisms described for the pathogenesis of recurrent miscarriage (Wang, et al., 
2016). The 25-hydroxyvitamin D3-1α-hydroxylase (CYP27B1) is an integral part of the vit. D 
metabolic pathway. This enzyme catalyzes localized conversion of pro-hormone 25-
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hydroxyvitamin D3 to the active form 1,25-dihydroxyvitamin D3 (Wang, et al., 2016). Wang et 
al. (2016) aimed to investigate the expression of CYP27B1 at the fetal-maternal interface in the 
first trimester of pregnancy and to determine if CYP27B1 was associated with recurrent 
miscarriage. Participants consisted of 20 women undergoing primary miscarriage and 20 women 
with recurrent miscarriage and another 20 women with normal pregnancy. Participants were 
examined for expressions of CYP27B1 mRNA and protein in villi and decidua (Wang, et al., 
2016). Researchers found that women who had recurrent miscarriage had significantly lower 
expressions of CYP27B1 mRNA and protein in villous and decidual tissues compared to normal 
pregnant women. Concluding that women with recurrent miscarriage have lower level of 
CYP27B1 expression in chorionic villi and decidua compared with normal pregnant women 
which may suggest that reduced CYP27B1 expression may be associated with recurrent 
miscarriage (Wang, et al., 2016).  
 Depression and Anxiety in Pregnancy and Vitamin D Deficiency 
 Ten to fifteen percent of women worldwide experience postpartum depression, which is a 
significant public health problem (Nielsen, et al., 2013). Some epidemiological studies have 
shown evidence of an association between vit. D insufficiency and depression along with other 
mood disorders. The role for vit. D in various brain functions has been suggested (Nielsen, et al., 
2013). Researchers hypothesized that a low vit. D status during pregnancy might increase the 
risk of postpartum depression and examined this in the research (Nielsen, et al., 2013). This was 
a case-control study among those in the Danish National Birth Cohort. Serum 25(OH)D3 levels 
were measured late in pregnancy among 605 women with postpartum depression and 875 
controls (Nielsen, et al., 2013). Researchers found that results did not support an association 
between low maternal vit. D concentrations during pregnant and the risk of postpartum 
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depression. Researchers instead found an increased risk of postpartum depression among women 
with the highest vit. D concentrations >31.6 ng/ml compared to those with levels between 20-
31.6 ng/ml (Nielsen, et al., 2013).   
 Huang et al. (2014) aimed to evaluate the associations between early pregnancy 25(OH)D 
levels and antepartum depression and anxiety symptoms (Huang, et al., 2014). Participants 
consisted of 498 pregnant women and researchers examined cross-sectional associations of early 
pregnancy serum 25(OH)D levels and depression and anxiety symptoms. Early pregnancy was a 
mean time of 15.4 weeks of gestation (Huang, et al., 2014). The mean 25(OH)D levels were 34.4 
ng/ml among participants. There were about 12% of the study participants who had moderate 
anxiety and depression symptoms. Those with the lowest levels of vit. D, <28.9 ng/ml, had 
higher depression and anxiety scores than those in the highest quartile but associations were not 
statistically significant. Researchers did find an inverse association with 25(OH)D levels with 
depressive symptoms among those who reported no leisure-time physical activity (Huang, et al., 
2014). Researchers concluded that there was modest evidence for inverse cross-sectional 
associations of early pregnant maternal vit. D levels with antepartum depression symptoms, 
which might be modified by physical activity (Huang, et al., 2014).  
 Of the two studies examining depression and anxiety as it relates to vit. D levels, one did 
not find a correlation and the other found a modest one. These studies show that an underlying 
mechanism is unclear for depression and anxiety during pregnancy as it relates to low vit. D 
levels. Further research is needed to investigate this potential relationship between depression, 
anxiety and vit. D levels.  
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 Birthweight Outcomes in Pregnancy and Vitamin D Deficiency  
Vitamin D status during pregnancy is linked to fetal grown and may impact infant growth 
(Eckhardt, Gernand, Roth, & Bodnar, 2015). Tian et al. (2016) measured maternal 25(OH)D 
levels in a nested case-control study (Tian, et al., 2016). Researchers tested the hypotheses that 
low maternal 25(OH)D levels during pregnancy are associated with decreased infant birthweight 
for gestational age, this association was modified by maternal race/ethnicity and infant sex. 
Participants consisted of 2,558 pregnant women from three cohorts. Maternal 25(OH)D levels 
were sampled at 4-29 weeks of gestation (Tian, et al., 2016). Among the non-Hispanic Black 
women, there was a positive association between 25(OH)D levels and infant birthweight for 
gestational age. Among the non-Hispanic White women, there was a positive association 
between 25(OH)D levels and infant birthweight for gestational age in male infants only (Tian, et 
al., 2016). Researchers concluded that serum 25(OH)D levels in early and mid-pregnancy were 
positively associated with infant birthweight for gestational age among non-Hispanic Black male 
and female infants and among non-Hispanic White male infants (Tian, et al., 2016). 
Huang et al. (2013) assessed whether self-reported maternal birthweight was associated 
with risk of early pregnancy vit. D deficiency (defined as 25(OH)D levels ≤20 ng/ml) among 658 
pregnant women (Huang, et al., 2013). Researchers adjusted for maternal characteristics and 
month of blood draw and noted a 100-gram higher maternal birthweight was associated with a 
5.7% decreased risk of early pregnant 25(OH)D deficiency. Low birthweight (<2500 grams) 
women were 3.7 times as likely to have an early pregnancy 25(OH)D deficiency compared with 
normal-birthweight women (Huang, et al., 2013). Researchers concluded that further research on 
shared developmental mechanisms that determine birthweight and vit. D homeostasis may 
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possibly help identify targets and preventative measures for adverse pregnancy and birth 
outcomes (Huang, et al., 2013).  
 Berg et al. (2013) aimed to investigate the contribution of maternal 25(OH)D to the 
association of maternal education and small for gestational age birth weight (Berg, Eijsden, 
Vrijkotte, & Gemke, 2013). A second aim was to examine whether 25(OH)D levels differ by 
overweight, season and maternal smoking. Researchers examined 2,274 pregnant women of 
Dutch ethnicity. Results showed that low-educated women had lower 25(OH)D levels compared 
to highly educated women. Women in the lowest 25(OH)D quartile had a higher risk of small for 
gestational age offspring (Berg, Eijsden, Vrijkotte, & Gemke, 2013). Researchers concluded that 
25(OH)D levels appear to be a modifiable contributor to the association between low maternal 
education and small for gestational age offspring particularly in overweight women and those 
who conceived in the winter months (Berg, Eijsden, Vrijkotte, & Gemke, 2013). Researchers 
also recommend that in those women it may be beneficial to increase the intake of vit. D either 
through dietary adjustments or through supplementation (Berg, Eijsden, Vrijkotte, & Gemke, 
2013). 
Eckhardt et al. (2015) examined the association between maternal vit. D status and infant 
anthropometry (Eckhardt, Gernand, Roth, & Bodnar, 2015). Participants consisted of 2,473 
mother child pairs and maternal 25(OH)D levels were obtained at ≤26 weeks of gestation. 
Maternal vit. D status, infant z-scores for length, head circumference, weight and BMI were 
measured at birth, 4, 8 and 12 months in infants (Eckhardt, Gernand, Roth, & Bodnar, 2015). 
Almost one quarter of mothers had 25(OH)D levels <12 ng/ml and those women were more 
often overweight, obese and unmarried, African-American women and had lower socioeconomic 
index compared to women who had 25(OH)D levels ≥12 ng/ml. Infants whose mothers had 
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25(OH)D levels <12 ng/ml were smaller at birth weight in respects to all anthropometric 
measures compared to those infants who had mothers with 25(OH)D levels ≥12 ng/ml (Eckhardt, 
Gernand, Roth, & Bodnar, 2015). Researchers found that low maternal vit. D status was 
associated with deficits at birth infants’ weight and BMI that were recouped during the first year 
of life. It was also found that associations with reduced measures of linear and skeletal growth 
were sustained from birth to 12 months (Eckhardt, Gernand, Roth, & Bodnar, 2015).   
Of the four studies examined, all found a relationship to birthweight outcome and vit. D 
levels with just one having mixed results. Race, maternal education and being overweight plays a 
role in this relationship of vit. D levels to birthweight outcomes. More research is needed to 
better understand the relationship to birth weight outcome and vit. D levels. It is suggested that 
larger randomized controlled trials are needed to assess the effects vit. D supplementation have 
on fetal growth.  
Multiple Outcomes Examined in Single Studies in Pregnancy and Vitamin D 
Deficiency  
 Flood-Nichols et al. (2015) analyzed the relationship between vit. D deficiency in the 
first trimester and subsequent clinical outcomes (Flood-Nichols, Tinnemore, Huang, Napolitano, 
& Ippolito, 2015). This study was a retrospective cohort. Participants consisted of 235 in their 
first trimester of women pregnant with their first child and with singleton gestations without 
significant medical problems (Flood-Nichols, Tinnemore, Huang, Napolitano, & Ippolito, 2015).  
Researchers found that 70% of participants were vit. D insufficient with serum concentrations 
<30 ng/ml. Adverse pregnancy outcomes comprised of preeclampsia, growth restriction, preterm 
delivery, gestational diabetes and spontaneous abortion (Flood-Nichols, Tinnemore, Huang, 
Napolitano, & Ippolito, 2015). Vitamin D deficiency was not associated with adverse pregnancy 
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outcomes in this study. Researchers did note a high percentage of young, reproductive-aged 
women with vit. D deficiency (Flood-Nichols, Tinnemore, Huang, Napolitano, & Ippolito, 
2015).  
 Domaracki et al. (2016) examined concentrations of 25(OH)D levels in Polish women 
who had normal pregnancies and in pregnancies complicated by gestational hypertension, 
preeclampsia or gestational diabetes mellitus (Domaracki, et al., 2016). Researchers analyzed the 
associations between maternal serum 25(OH)D levels and the risk of gestational hypertension, 
preeclampsia and gestational diabetes mellitus among 207 pregnant women. Among participants, 
171 women had pregnancy-related complications, the control group consisted of 36 women with 
normal pregnancies (Domaracki, et al., 2016). Participants with hypertension did not differ 
significantly from the controls in terms of serum 25(OH)D levels (18.2 vs 22.1 ng/ml). There 
was a highly significant difference found in serum 25(OH)D concentrations among women with 
preeclampsia and the controls (14.75 vs 22.1 ng/ml) (Domaracki, et al., 2016). Gestational 
diabetes mellitus was not associated with significant differences in 25(OH)D levels. Researchers 
found that 25(OH)D deficiency is common among pregnant Polish women and that low 
concentrations of 25(OH)D may play a role in the etiopathogenesis of preeclampsia. It is 
suggested that assessment of 25(OH)D levels during pregnancy may be important for the 
identification of women at increased risk of preeclampsia (Domaracki, et al., 2016).  
 Zhou et al. (2014) aimed to assess maternal 25(OH)D status and its association with 
pregnancy outcomes in a prospective observational study that was carried out in Guangzhou, 
China (latitude 23˚ North) (Zhou, et al., 2014). Participants consisted of 2,960 pregnant women 
and 100 healthy controls. Among participants, 18.9% had low 25(OH)D levels ≤20 ng/ml and 
48.6% had medium levels 21-29 ng/ml (Zhou, et al., 2014). Serum 25(OH)D levels were the 
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highest in summer months and lowest in the winter months. Most maternal and infant outcomes 
were not associated with 25(OH)D levels but the prevalence of GDM and preterm delivery were 
noted in the high-level group with 25(OH)D levels ≥30 ng/ml than with the low and medium 
level groups (Zhou, et al., 2014).   
 Moller et al. (2012) studied the effects of pre-conception 25(OH)D levels on changes for 
pregnancy as well as the effects during pregnancy on the risk of miscarriage, birth weight and 
length, Apgar score and head circumferences (Moller, Streym, Heickendorff, Mosekilde, & 
Rejnmark, 2012). Participants consisted of 153 healthy Caucasian women with pregnancy plans 
and 75 non-pregnant, age-matched women were followed as controls. Baseline 25(OH)D levels 
were 23.6 ng/ml, 31% had levels < 23.6 ng/ml and 12% had levels above 32 ng/ml (Moller, 
Streym, Heickendorff, Mosekilde, & Rejnmark, 2012). Serum 25(OH)D levels were not 
associated with the changes of conceiving or overall risk of miscarriage; however, those women 
with a miscarriage in their second trimester had lower 25(OH)D levels compared to those 
without miscarriage. Levels of 25(OH)D before or during pregnancy were not associated with 
gestational length or infant parameters. Researchers concluded that 25(OH)D levels prior to 
conception did not affect fertility or pregnancy outcomes, but low 25(OH)D levels may be 
associated with an increased risk of late miscarriage (Moller, Streym, Heickendorff, Mosekilde, 
& Rejnmark, 2012).   
 When examining studies that had several outcomes there were mixed correlations 
between vit. D and outcomes. Some studies found no correlation to adverse pregnancy outcomes 
and 25(OH)D levels. Some studies found a correlation between one adverse pregnancy outcome 
but not all the adverse outcomes. Correlations were found to exist between 25(OH)D levels and 
preeclampsia, GDM, preterm delivery, miscarriage in the second trimester.  
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Current Intake of Vitamin D by Pregnant Women 
 One randomized controlled trial among women with a single pregnancy were examined 
at 12-16 weeks of gestation. Women were supplemented with 400, 2,000 or 4,000 IU of vit. D3 
daily until they delivered (Hollis, Johnson, Hulsey, Ebeling, & Wagner, 2011). Maternal and 
neonatal circulating 25(OH)D levels were examined at delivery. There were 350 women that 
continued in the study until delivery. The mean 25(OH)D level at delivery and one month before 
delivery was significantly different. Those who took 4,000 IU had the greatest percent in their 
group who achieved sufficiency. There were no differences between groups on safety measures 
and there were no adverse events that were attributed to vit. D supplementation or circulating 
25(OH)D levels (Hollis, Johnson, Hulsey, Ebeling, & Wagner, 2011). Supplementing with 4,000 
IU of vit. D for pregnant women was safe and the most effective, compared to 400 IU and 2,000 
IU in achieving sufficiency among women and their neonates regardless of race. The researchers 
concluded that the current estimated average requirement was not effective at achieving adequate 
circulating 25(OH)D, especially among African Americans (Hollis, Johnson, Hulsey, Ebeling, & 
Wagner, 2011). 
A collaborative, multi-center, birth cohort study was conducted in nine European 
countries whom obtained standardized baseline information from 12,049 participants (Oliver, et 
al., 2014). Pregnancy recommendations were also obtained from all countries. The standardized 
baseline questionnaire data included details of food intake, nutritional supplement use, exposure 
to cigarette smoke and socio-demographic data during pregnancy (Oliver, et al., 2014). Vitamin 
D supplementation among participants in the entire cohort was very poor; 0.3%-5.1%. Only four 
out of nine countries in this cohort made specific recommendations for pregnant women to take 
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vit. D. Researchers thought this was due to the assumption that sunshine exposure was adequate 
among participants (Oliver, et al., 2014). 
Morisset et al. (2016) examined iron, vit. D and calcium intakes from diet and 
supplements in relation to maternal characteristics (Morisset, et al., 2016). Data were collected in 
1,186 pregnant women from the Maternal-Infant Research on Environmental Chemicals Study, 
which was a cohort study among pregnant women recruited from 10 Canadian sites between 
2008-2011. Researchers administered a food frequency questionnaire to obtain rankings of iron, 
calcium and vit. D intake at 16-21 weeks of gestation. Supplement intake was obtained from a 
separate questionnaire at 6-13 weeks of gestation (Morisset, et al., 2016). Intake of supplements 
was an important contributor to total iron intake and total vit. D intake while the contrary was 
observed for calcium intake. Being born outside of Canada was associated significantly with 
lower total intakes of iron, vit. D and calcium. Supplement use was a consistently positive 
indicator when maternal age was over 30 years and with women who held university degrees. 
Researchers found that supplement intake was a major contributor to total iron and vit. D intakes 
and higher education level and being over 30 years old (Morisset, et al., 2016).   
 Roth et al. (2013) conducted a double-blind placebo-controlled randomized trial to 
evaluate effectiveness of a high-dose vit. D supplementation in the prenatal third trimester and 
outcomes it had on the maternal and neonatal (cord blood) serum 25(OH)D (Roth D. E., et al., 
2013). Participants consisted of women 18-<35 years old, at 26-<29 weeks of gestation. There 
were 130 women who participated. Women were randomized 1:1 to one of two intervention 
groups. The first intervention group was given a placebo (n=63) and the second intervention 
group was given 35,000 IU of vit. D3 (vit. D3) (n=67) until delivery (Roth D. E., et al., 2013). 
Baseline levels of serum 25(OH)D concentrations were similar among the vit. D and placebo 
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groups. At delivery, serum 25(OH)D levels were significantly higher in the vit. D group versus 
the placebo group. One hundred percent of the supplemented mothers and 95% of the neonates 
attained a serum 25(OH)D level greater than 20 ng/ml versus 21% of mothers and 19% of 
neonates in the placebo group (Roth D. E., et al., 2013). There were no supplement-related 
adverse events or major adverse pregnancy outcomes among both study groups. It is concluded 
from this study that doses up to 35,000 IU per week of vit. D3 may be cautiously used in 
research to help establish clinical effects and safety of vit. D3 supplementation among pregnant 
women (Roth, et al., 2013).  
 An open-label, parallel group, prospective randomized and controlled trial was conducted 
to assess the efficacy and safety of various doses of vit. D during pregnancy (Mir, et al., 2017). 
There were 87 women who completed the study. Subjects were assigned to four treatment 
groups. Women were enrolled from their first trimester to the start of the second trimester 
depending on when the pregnancy was confirmed. Group 1 took 1,000 IU of vit. D daily, group 2 
took 30,000 IU of vit. D monthly, group 3 took 2,000 IU of vit. D daily and group 4 took 60,000 
IU bolus of vit. D monthly. Post supplementation levels of 25(OH)D were higher in the 2,000 IU 
vit. D per day (group 3) and 60,000 IU vit. D per month (group 4) group (called group 2K) than 
the 1,000 IU vit. D per day (group 1) and 30,000 IU vit. D per month (group 3) group (called 
group 1K) (Mir, et al., 2017). Serum 25(OH)D in group 2K were 42.9±12.8 ng/ml compared to 
37.0 +/-10.6 ng/ml in group 1K; p value was 0.023. The results also showed that group 4 (60,000 
IU of vit. D per month) had significantly higher serum 25(OH)D levels than subjects in group 2 
(30,000 IU of vit. D per month). Supplementation with 2,000 IU of vit. D per day or 60,0000 IU 
of vit. D per month was effective and safe in achieving vit. D sufficiency among pregnant 
women. In this study, vit. D sufficiency is defined as serum 25(OH)D levels of 30 ng/ml or 
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more. This study specifically demonstrates that daily or monthly doses of vit. D are equally 
effective in correcting vit. D levels at term. This study concludes that starting at 16 weeks of 
gestation, vit. D supplementation of 2,000 IU per day or the monthly equivalent dose is more 
effective in achieving a higher vit. D level throughout pregnancy without an increase in the risk 
of toxicity to the mother or neonate (Mir, et al., 2017).  
Aghajafari et al. (2016) conducted a study to determine if pregnant women consumed the 
recommended vit. D through diet alone or through diet and supplementation and whether they 
achieved the current reference range of vit. D status when their reported dietary intake met 
current recommendations (Aghajafari, et al., 2016). Blood samples were collected in the second 
trimester from 537 women. They found a significant relationship between maternal reported 
dietary vit. D intake, through diet and supplements, and 25(OH)D and 3-epi-25-
hydroxycholecalciferol levels. Women who had serum 25(OH)D concentrations <30 ng/ml 
reported consuming less vit. D through diet and supplements compared to those with serum 
levels ≥30 ng/ml (Aghajafari, et al., 2016). They also found that 44% of pregnant women with 
higher socioeconomic status reported vit. D intake through diet and supplements did not meet the 
DRI recommendations of 600 IU. Twenty percent of pregnant women had serum 25(OH)D 
levels <30 ng/ml despite over half of these women reporting intakes more than 600 IU/day of vit. 
D through diet and supplements. Fifty percent of the women who participated in this study were 
classified as vit. D insufficient, defined as vit. D level <30 ng/ml. Aghajafari et al. (2016) 
demonstrated that the current RDA of 600 IU of vit. D per day may not be enough to achieve vit. 
D status above 30 ng/ml in some pregnant women who reside at higher latitudes, and 
recommendations for pregnant women need to be re-evaluated (Aghajafari, et al., 2016).  
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 Holick et al. (2011) created guidelines for clinicians for the evaluation, treatment and 
prevention of vit. D deficiency, which emphasized care of patients who are at risk for deficiency 
(Holick, et al., 2011). The task force which was reviewed by the Endocrine Society’s Clinical 
Guidelines Subcommittee, Clinical Affairs Core Committee and cosponsoring associations 
acknowledged that vit. D deficiency is very common in all age groups and that few foods contain 
vit. D. Specific recommendations for pregnant and lactating women were evaluated and they 
suggest that this population requires 600 IU of vit. D per day and recognize that 1,500-2,000 IU 
per day of vit. D might be needed to maintain serum levels of 25(OH)D above 30 ng/ml (Holick, 
et al., 2011). The committee also suggested that maintenance of tolerable upper limits (UL) of 
vit. D only be exceeded with medical supervision. This amount is 4,000 IU of vit. D for everyone 
over 8 years old and potential for 10,000 IU per day of vit. D for children and adults 19 years and 
older to correct vit. D deficiency. The committee also suggested that adults who are vit. D 
deficient be treated with 50,000 IU of vit. D2 or vit. D3 once a week for 8 weeks or using the 
equivalent of 6,000 IU of vit. D2 or vit. D3 daily for 8 weeks to achieve serum 25(OH)D levels 
above 30 ng/ml and then followed by a maintenance dose of 1,500-2,000 IU per day of vit. D 
(Holick, et al., 2011).  
 McGowan et al. (2011) examined food groups that contribute to vit. D intake among 
pregnant women (McGowan, Byrne, Walsh, & McAuliffe, 2011). Researchers aimed to 
determine dietary intakes of vit. D throughout pregnant among 64 women and to determine the 
main food groups that contribute to vit. D intake. Dietary intake of vit. D ranged from 76-84 IU 
per day during pregnancy, with 80% below the current recommendations. The main food groups 
contributing to vit. D intake were meat, egg and breakfast cereals (McGowan, Byrne, Walsh, & 
McAuliffe, 2011). Researchers pointed out that oily fish is the best dietary source of vit. D 
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supplementation and this was consumed by less than 25% of women. Researchers point out that 
there needs to be more education among pregnant women and they also question the role of vit. 
D supplementation and highlight the contribution of other food groups that are more frequently 
consumed (McGowan, Byrne, Walsh, & McAuliffe, 2011).  
 There continues to be controversy over what constitutes vit. D adequacy and how much 
vit. D is needed to replete deficiency or maintain adequacy. Most studies to date do not show 
consistency with what the IOM recommends for vit. D and the DRI, especially during 
pregnancy. More research continues to be done on vit. D levels during pregnancy and there 
continue to be more studies on vit. D supplementation during pregnancy and what is considered 
safe dosages.  
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CHAPTER 3. DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
 Vitamin D deficiency has substantial implications for human health throughout life and 
specifically during pregnancy. The IOM committee concluded that only skeletal health provided 
the one contributing outcome for establishing the DRI for calcium and vit. D (Institute of 
Medicine, 2011). Recent research after 2011 has shown that several outcomes related to 
pregnancy might also be a contributing factor for reevaluating the DRI for vit. D. Vitamin D 
during pregnancy is crucial for transfer of calcium from the mother to child for proper skeletal 
development, but it has also been suggested that maternal vit. D deficiency can cause a myriad of 
other issues during pregnancy. This review summarized the current recommendations for vit. D 
and how that compares to what pregnant women are taking and what new research is saying after 
2011. It also examined adequacy and deficiency of vit. D during pregnancy, sources of vit. D and 
optimum levels of vit. D. Women of childbearing age and other healthcare professionals will 
benefit from knowing what the current recommendations are for vit. D intake to help prevent 
potential adverse effects deficiency might have on pregnancy. Due to numerous variables having 
effects on serum concentrations of 25(OH)D, it is difficult to narrow down what amounts of vit. 
D should be recommended during pregnancy and at times how they should be recommended. 
Since one of the main sources of vit. D is sun exposure, yet the recommendations are to limit sun 
exposure to avoid cancer risk, makes it difficult to recommend any certain way to obtain vit. D, 
through supplements, foods or sun exposure.  
Thirteen studies that examined the prevalence of vit. D among pregnant women showed 
that vit. D is common. Despite environments that are sunny, there continues to be vit. D 
deficiency among pregnant women. It has been shown that increased vit. D supplement use and 
increased intake of vit. D rich foods decrease vit. D deficiency and inadequacy (Zhao, Ford, Tsai, 
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Li, & Croft, 2012). With one study stating that taking a multivitamin supplement was 
significantly associated with higher 25(OH)D levels (Song, et al., 2013). Skin color also played a 
role in vit. D levels among pregnant women and seasonal variation (Luque-Fernandez, et al., 
2013) (Lundqvist, Sandstrom, Stenlund, Johansson, & Hultdin, 2016).  
When examining vit. D deficiency and the impact it has on pregnancy there are mixed 
results and if there is relevance to serum 25(OH)D levels. Of the studies examined 11 showed 
correlation between serum 25(OH)D levels and adverse outcomes of pregnancy, 6 showed no 
correlation and 6 showed mixed results.  
 Limitations of this review include only using EBSCO host as a search engine through the 
online NDSU library. Another limitation is that only one person conducted the review process. 
Eligibility of research for inclusion and data extraction was assessed by just one person along 
with subjective judgements of that one person, whereas two persons going through eligibility of 
research might have been better. Choosing only the English language is another limitation since 
many research articles are also in other languages.  
After examining research after 2011 when the DRIs were put out, it is unclear if bone 
health is the only basis for DRI development. It appears that more research is needed prior to the 
IOM conducting another evaluation on the DRI for calcium and vit. D. There continues to be a 
gap in high quality, larger randomized trials to evaluate the role of vit. D supplementation in 
pregnancy. Future research should continue to examine if an increase of serum 25(OH)D levels 
is associated with improved maternal and infant outcomes in populations with different skin 
pigmentation, sunscreen habits, BMI, GDM, preeclampsia and those living at different latitudes. 
Furthermore, there needs to be more information on the most effective and optimal safe dosage 
regimen of vit. D during pregnancy and to identify the safest repletion dose regimen for those 
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who are identified as deficient during pregnancy. At this time, it is not recommended that vit. D 
supplementation be given as routine antenatal care to all women to improve adverse pregnancy 
outcomes. Until further research is conducted health care professionals and RDNs should 
continue to advise pregnant women to consume a general healthful diet, a prenatal multivitamin 
that contains vit. D and to obtain vit. D through safe sun exposure if they are able.  
 Looking at current recommendations for vit. D and how it compares to more recent 
research. Numerous studies conducted after 2011 concluded that the current recommendations of 
600 IU per day of vit. D is not effective at achieving adequate circulating serum levels of 
25(OH)D. Research has shown a variety of dosing regimens safe and effective for pregnant 
women in helping to achieve sufficient 25(OH)D levels.  Supplementation amounts varied in the 
research examined in this paper and research has demonstrated that the current RDA of 600 IU 
of vit. D per day might not be enough to achieve a vit. D status above 30 ng/ml among some 
pregnant women. Researchers felt that recommendations for pregnant women needed to be re-
evaluated. It appears that intakes of ~2,000 IU per day is likely safe to consume during 
pregnancy. Studies show that there is a disconnect between the IOM and ACOG’s definitions of 
adequate intake of vit. D compared to what research suggests is adequate after 2011.  
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APPENDIX. SUMMARY OF ARTICLES, VITAMIN D DEFICIENCY AND IMPACT 
ON PREGNANCY AND CURRENT INTAKE OF VITAMIN D BY PREGNANT 
WOMEN 
Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Aghajafari 
et al. 
(2016) 
537 pregnant women, 
March 2009-July 2012 
Secondary 
analysis of a 
prospective 
cohort study 
Determine if pregnant 
women consumed the 
recommended vit. D 
through diet alone or 
through diet and 
supplements and if they 
achieved the current 
reference range vit. D 
status when their 
reported dietary intake 
met the current 
recommendations.   
The current RDA of 600 
IU per day may not be 
adequate to achieve vit. D 
status >30 ng/ml in some 
pregnant women who are 
residing at higher 
latitudes and the current 
vit. D recommendations 
may need to be re-
evaluated.  
Alvarez-
Fernandez 
et al. 
(2015) 
257 pregnant women 
with suspicion of 
preeclampsia in Oviedo, 
Spain, January 2010-
March 2013 
Retrospective
, full-blinded 
cohort 
Assess the role of 
25(OH)D concentrations 
and the soluble fms-like 
tyrosine kinase 1 to 
placental growth factor 
ratio in the development 
of early and late onset 
preeclampsia and to 
evaluate the relationship 
between 25(OH)D and 
biomarkers. 
Low vit. D status in 
women with suspected 
late-onset preeclampsia 
increases the risk of 
imminent development of 
the disease. 
Arnold et 
al. (2015) 
135 pregnant women 
with GDM and 517 
without GDM 
Nested case-
cohort study 
Examined associations 
of vit. D status with 
GDM.  
Early pregnancy vit. D 
levels, particularly 
25(OH)D3 is inversely 
associated with GDM 
risk.  
Barati et al. 
(2016) 
126 pregnant Pakistanis 
women, February 2014-
February 2015 
Prospective 
cohort 
Evaluate the serum 
levels of vit. D among 
pregnant women in their 
first prenatal visit. 
Despite an intense and 
sunny climate in almost 
all seasons in Pakistan, 
vit. D deficiency can be 
found in abundance. 
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Berg et al. 
(2013) 
2,274 pregnant women 
of Dutch ethnicity 
Population-
based cohort 
study 
Investigate the 
contribution of maternal 
25(OH)D vit. D to the 
association of maternal 
education and small for 
gestational age birth 
weight and to also 
examine whether the 
contribution of 25(OH)D 
differs by overweight, 
season and maternal 
smoking. 
25(OH)D appears to be a 
modifiable contributor to 
the association between 
low maternal education 
and small for gestational 
age offspring, in 
overweight women and 
women who conceived in 
the winter.  
Bergstrom 
et al. 
(2014) 
68 pregnant immigrant 
women and 51 native 
Swedish women, 2006-
2010 
Population-
based cohort 
study 
Determine the 
prevalence of vit. D 
insufficiency in pregnant 
immigrant women 
assessed by the levels of 
25(OH)D, parathyroid 
hormone and alkaline 
phosphatase and 
correlation to 
musculoskeletal pain. 
Hypovitaminosis D is 
prevalent in immigrant 
women living in Sweden, 
there is a negative 
correlation between 
changes in 25(OH)D and 
pain from gestational 
week 12-postpartum. 
Cadario et 
al. (2015) 
533 Maternal and 
neonatal pairs, April 1, 
2012-March 30, 2013 
Cross 
sectional 
Investigate 25(OH)D 
levels in maternal serum 
and neonatal blood spots 
among native and 
migrant populations 
living in Novara, Italy. 
vit. D insufficiency in 
pregnancy and in 
newborns is frequent, 
especially among 
migrants. 
DeLaine et 
al. (2013) 
472 Pregnant women, 
three, four-week periods 
2009-2010 
Prospective 
audit 
Evaluate the vit. D status 
of pregnant women at 
their institution and 
assess the sensitivity of 
the current risk-based 
screen guideline. 
Risk-based screening 
criteria for vit. D 
deficiency in pregnancy 
fails to detect over half of 
vit. D deficient women. 
Dodds et 
al. (2016)  
395 pregnant women 
with GDM and 1,925 
controls in Nova Scotia 
and Quebec, October 
2002-July 2005 
Nested case-
control study 
Explored the association 
between 25(OH)D 
concentration and GDM 
and determined if there 
was an interaction 
between smoking and 
25(OH)D. 
Confirms an inverse 
association of vit. D status 
with GDM risk, 
particularly among 
women who smoke 
during pregnancy. 
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Domaracki 
et al. 
(2016) 
207 pregnant women, of 
which 171 with 
pregnancy-related 
complications and 36 
women with normal 
pregnancies, 2013-2015 
Observational 
study 
Examine concentrations 
of 25(OH)D in Polish 
women with normal 
pregnancies and 
pregnancies complicated 
by gestational 
hypertension, 
preeclampsia or GDM.  
25(OH)D deficiency is 
common among pregnant 
Polish women.  
Eckhardt et 
al. (2014) 
2,473 mother-child pairs, 
1959-1965 
Multi-centre 
cohort study 
Examine the association 
between maternal vit. D 
status and infant 
anthropometry 
Low maternal vit. D 
status was associated with 
deficits at birth in infant 
weight and BMI that were 
recouped across the first 
year of life. Associations 
with reduced measures of 
linear and skeletal growth 
were sustained from birth 
to 12 months.  
Flood-
Nichols et 
al. (2015) 
235 pregnant women, 
2014 
Retrospective 
cohort study 
Analyze the relationship 
between vit. D 
deficiency in the first 
trimester and subsequent 
clinical outcomes. 
vit. D deficiency did not 
associate with adverse 
pregnancy outcomes. 
There was a high 
prevalence of vit. D 
deficiency in young, 
reproductive -aged 
women. 
Halicioglu 
et al. 
(2011) 
258 healthy pregnant 
women in Izmir, Turkey, 
March 2008-May2008 
Prospective 
cohort 
Measure serum 
25(OH)D concentrations 
of pregnant women in 
their last trimester and 
their neonates at delivery 
to determine the factors 
associated with maternal 
serum 25(OH)D 
concentrations. 
Despite a sunny 
environment, vit. D 
deficiency and 
insufficiency are highly 
prevalent among mothers 
and their neonates, 
generally due to the life 
style and nutritional status 
of mothers.  
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Hollis et al. 
(2011) 
350 pregnant women in 
South Carolina, January 
4, 2004-July 31, 2009 
Double blind 
randomized 
clinical trial 
Examine 
maternal/neonatal 
circulating 25(OH)D 
levels at delivery, with 
secondary outcomes 
25(OH)D ≥32 ng/ml 
achieved and 25(OH)D 
concentration required to 
achieve maximal 
1,25(OH)₂D production.  
vit. D supplementation of 
4,000 IU/day for pregnant 
women was safe and most 
effective in achieving 
sufficiency in all women 
and their neonates 
regardless of race while 
the current estimated 
average requirement was 
ineffective at achieving 
adequate 25(OH)D levels, 
especially among African 
Americans.   
Huang et 
al. (2013) 
658 pregnant women, 
1996-2008 
Prospective 
cohort study 
Assessed whether self-
reported maternal 
birthweight was 
associated with risk of 
early pregnancy vit. D 
deficiency.  
There is a relationship 
between maternal 
birthweight and risk of 
vit. D deficiency during 
early pregnancy.   
Huang et 
al. (2014) 
498 pregnant women in 
Seattle, Washington, 
April 2009-Decmeber 
2010 
Cross-
sectional 
study  
Evaluate the association 
between early pregnancy 
25(OH)D levels and 
antepartum depression 
and anxiety symptoms 
and potential modifiers.  
There is modest evidence 
for inverse cross-sectional 
associations of early 
pregnancy maternal vit. D 
levels with antepartum 
depression symptoms. 
These associations may 
be modified by physical 
activity. 
Josefson et 
al. (2016) 
360 pregnant women, 
July 2000-April 2006 
Prospective 
observational 
Examine associations 
between maternal BMI 
and maternal and cord 
blood levels of 25(OH)D 
in full term neonates 
born to single racial 
cohort residing at similar 
latitude and examine 
associations between 
maternal glucose 
tolerance with maternal 
levels of 25(OH)D and 
the relationship between 
cord blood 25(OH)D 
levels and neonatal size. 
Maternal levels of 
25(OH)D are associated 
with maternal BMI.  
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Lechterma
nn et al. 
(2014) 
63 pregnant women at 
delivery, January 2005-
December 2008 
Prospective 
cohort 
Investigate the influence 
of season on maternal 
vit. D status and 
placental vit. D 
metabolism. 
Women with 
preeclampsia displayed 
lower vit. D levels in 
response to seasonal 
changes. 
Lindsay et 
al. (2015) 
100 pregnant women 
with BMI 30.0-39.9 
kg/m², March-November 
2012 
Prospective 
observational 
study 
Assess maternal dietary 
and lifestyle habits in an 
obese cohort to identify 
priority areas to be 
addressed in future 
studies and in clinical 
practice. 
Macronutrient intakes 
among obese pregnant 
women were not 
compliant to healthy 
eating guidelines, intakes 
of calcium, iron, folate 
and vit. D were poor from 
diet alone. 
Liu et al. 
(2017) 
98 pregnant women with 
GDM in Beijing, 
October 2013-July 2015 
Case-control 
study 
Study the vit. D 
nutritional status of 
pregnant women with 
GDM in the middle and 
late pregnancy and 
analyze the different 
sources of vit. D intake.  
20.45% of pregnant 
women with GDM in 
their middle and late 
pregnancy are deficiency 
in vit. D though their vit. 
D levels were higher than 
the general population.  
Lundqvist 
et al. 
(2016) 
184 pregnant women in 
Northern Sweden, 
September 2006-March 
2009 
Longitudinal  Assess vit. D status 
during pregnancy and 
postpartum and identify 
the factors associated 
with vit. D status in 
pregnant women.  
Gestational and 
postpartum week, season, 
dietary intake of vit. D 
and vitamin 
supplementation were all 
significantly associated to 
plasma 25(OH)D levels. 
Luque-
Fernandez 
et al. 
(2013) 
2,583 non-Hispanic 
Black and White women, 
1995-2008 
Prospective 
cohort 
Evaluate seasonal 
variation of 25(OH)D 
among pregnant women, 
focusing on patterns and 
determinants of 
variation. 
Non-Hispanic Black 
women had lower average 
25(OH)D concentrations 
throughout the year and 
smaller seasonal variation 
levels compared to non-
Hispanic White women. 
McGowan 
et al. 
(2011) 
64 pregnant women, 
years not specified 
Prospective 
observational 
study 
Determine dietary 
intakes of vit. D 
throughout pregnancy. 
Main food groups 
contributing to vit. D 
intake were meat (oily 
fish), eggs and breakfast 
cereals. Oily fish is the 
best dietary source of vit. 
D.   
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
McDonnell 
et al. 
(2017) 
1,064 pregnant women, 
September 2015-
December 2016 
Prospective 
cohort study 
Determine if the reported 
inverse relationship 
between maternal 
25(OH)D and preterm 
birth risk could be 
replicated at the Medical 
University of South 
Carolina, treating a 
large, diverse population.  
Maternal 25(OH)D levels 
≥40 ng/ml were 
associated with 
substantial reduction in 
preterm birth risk in a 
large, diverse population 
of women.  
Mir et al. 
(2017) 
87 pregnant women, 
2013 
Open-label, 
parallel 
group, 
prospective 
randomized 
and 
controlled 
trial 
Assess the efficacy and 
safety of various doses 
of vit. D during 
pregnancy. 
Starting at 16 weeks of 
gestation, vit. D 
supplementation of 2,000 
IU per day or the monthly 
equivalent dose is more 
effective in achieving 
higher vit. D levels 
throughout pregnancy 
without an increase in the 
risk of toxicity to the 
mother or neonate. 
Mirzakhani 
et al. 
(2016) 
816 pregnant women, 
2009-2013 
Nested case-
control study 
Assessed the effect of 
vit. D supplementation, 
initiated in early 
pregnancy, on the 
development of 
preeclampsia.  
vit. D supplementation 
initiated in weeks 10-18 
of gestation did not 
reduce preeclampsia 
incidence. vit. D levels 
≥30 ng/ml at trial entry 
and in late pregnancy 
were associated with a 
lower risk of 
preeclampsia.  
Moller et 
al. (2012) 
153 healthy Caucasian 
women with pregnancy 
plans and 75 non-
pregnant, age-matched 
women in Aarhus, 
Denmark, October 2006-
Jnaury 2008 
Population-
based 
controlled 
cohort study 
Study the effects of pre-
conception 25(OH)D 
levels on chances for 
pregnancy as well as the 
effects of 25(OH)D 
during pregnancy on the 
risk of miscarriage, 
birthweight and length, 
Apgar score and head 
circumference.  
25(OH)D levels did not 
affect fertility or 
pregnancy outcomes, 
although low 25(OH)D 
levels may be associated 
with an increased risk of 
late miscarriage. 
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Morisset et 
al. (2016) 
1,186 pregnant women 
in Canada, 2008-2011 
Prospective 
cohort 
Examine iron, vit. D, and 
calcium intakes from 
diet and supplements in 
relation to maternal 
characteristics.  
Among Canadian women, 
the probability of having 
lower iron, vit. D and 
calcium intakes is higher 
among those born outside 
Canada; supplement 
intake is a major 
contributor to total iron 
and vit. D intakes; and 
higher education level and 
age over 30 years are 
associated with 
supplement intake.  
Neilsen et 
al. (2013) 
605 women with 
postpartum depression 
and 875 controls in 
Danish women,  
Nested case-
control study 
Determine whether low 
vit. D status during 
pregnancy was 
associated with 
postpartum depression.  
No association between 
low maternal vit. D levels 
during pregnancy and risk 
of postpartum depression. 
It is noted that an 
increased risk of 
postpartum depression 
was found among women 
with the highest vit. D 
concentrations. 
O’Brien et 
al. (2017) 
334 pregnant women in 
Dublin, Ireland, 2007-
2011 
Secondary 
data analysis 
of a 
randomized 
control trial 
Determine if exposure to 
winter and low maternal 
25(OH)D levels in early 
pregnancy were 
associated with maternal 
glucose metabolism.  
Women who attended 
their first antenatal visit 
during the months of 
extended winter were 
more likely to have raised 
insulin resistance in early 
pregnancy, which had a 
lasting association to 28 
weeks, and was 
independent of 25(OH)D 
levels.  
Oliver et 
al. (2014) 
12,049 pregnant women, 
October 2005-February 
2010 
Collaborative
, multi-center 
birth cohort 
Assess maternal dietary 
habits across Europe 
during pregnancy in 
relation to their national 
pregnancy 
recommendations.  
Maternal dietary habits 
during pregnancy varies 
significantly across 
Europe and may be 
influenced by national 
recommendations.  
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Author Population/Duration of 
Study 
Type of 
Study 
Aim Major Findings 
Pratumvinit 
et al. 2015 
147 Thai pregnant 
women, September 
2011-January 2012 
Cross 
sectional 
Determine the vit. D 
status in pregnant 
women and examine the 
factors associated with 
vit. D deficiency. 
vit. D deficiency is 
common among pregnant 
Thai women. The 
prevalence of vit. D 
deficiency is increased in 
women who have a lower 
pre-pregnancy BMI and 
who’s 25(OH)D levels 
were collected in the 
winter. 
Rezavand 
et al. 
(2016) 
120 healthy pregnant 
women and 120 women 
who had preeclampsia, 
2014 
Case-control 
study 
Compare the serum 
levels of vit. D and 
interleukin-6 in healthy 
pregnant women with 
those with preeclampsia 
Inflammatory factors and 
cytokines such as 
interleukin-6 can be 
considered as risk factors 
for preeclampsia. 
Ringrose et 
al. (2011) 
78 participants with 
hypertension and 109 
controls, September-
October 2008 and 
January-March 2009 
Case-control 
study 
Examine the association 
between vit. D status and 
hypertension in late 
pregnancy. 
There is a high prevalence 
of vit. D deficiency in 
pregnant women recruited 
in Saskatoon, 
Saskatchewan. Women 
with low circulating vit. D 
concentrations are more 
likely to have 
hypertension. 
Rodriguez 
et al. 
(2016) 
2,036 pregnant women 
in Spain, November 
2003-February 2008 
Population-
based cohort 
study 
Prevalence and 
determinants of vit. D 
insufficiency and 
deficiency in pregnancy. 
vit. D insufficiency and 
deficiency are highly 
prevalent in pregnancy. 
Roth et al. 
(2012) 
34 non-pregnant and 27 
pregnant women in 
Dhaka, Bangladesh, July 
2009-February 2010 
Double blind 
randomized 
clinical trial 
Generate preliminary 
pharmacokinetic and 
safety data to inform the 
design of 
supplementation 
regimens for use in 
future larger-scale trials 
of antenatal vit. D 
supplementation in 
Bangladesh. 
The response to a single 
70,000 IU dose of vit. D3 
was similar in pregnant 
and non-pregnant women 
and consistent with 
previously studies in non-
pregnant adults.  
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Study 
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Song et al. 
(2013) 
125 pregnant women in 
Beijing, December 2010-
February 2011 
Longitudinal 
study 
Assess the vit. D status 
of pregnant women 
residing in Beijing in 
winter and evaluate the 
impact of maternal 
factors on 25(OH)D 
levels. 
Pregnant women in 
Beijing are at very high 
risk of vit. D deficiency in 
winter, duration of sun 
exposure and use of 
multivitamin were the 
most important, 
determinants for vit. D 
status. 
Tian et al. 
(2016) 
2,558 pregnant women, 
1996-2008 
Nested case-
control study 
Investigate associations 
between maternal serum 
25(OH)D levels and 
infant birthweight for 
gestation age, including 
potential effect 
modification by maternal 
race/ethnicity and infant 
sex.  
Maternal serum 
concentrations of 
25(OH)D in early and 
mid-pregnancy were 
positively associated with 
birthweight for gestational 
age among non-Hispanic 
Black male and female 
infants and non-Hispanic 
White male infants.  
Wang et al. 
(2016) 
20 women undergoing 
primary miscarriage, 20 
women with recurrent 
miscarriage, 20 women 
with normal pregnancy 
in Xi’an Jiaotong, China, 
October 2013-October 
2014 
Observational 
study 
Investigate the 
expression of 25-
hydroxyvitamin D₃-1α-
hydroxylase at the fetal-
maternal interface in the 
first trimester pregnancy 
and to determine 
whether 25-
hydroxyvitamin D₃-1α-
hydroxylase was 
associated with recurrent 
miscarriage.  
Women with recurrent 
miscarriage have a lower 
level of 25-
hydroxyvitamin D₃-1α-
hydroxylase expression in 
chorionic villi and 
decidua compared with 
normal pregnant women. 
Xioa et al. 
(2015) 
5,823 pregnant women 
from January 2011-June 
2012 
Cross 
sectional 
observational 
study 
Evaluate vit. D status of 
women in Eastern China 
during the second 
trimester of pregnancy. 
There is a high prevalence 
of vit. D deficiency 
among pregnant Chinese 
women and 25(OH)D 
levels varied according to 
season and air 
temperature. 
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Yu et al. 
(2013) 
90 pregnant women with 
preeclampsia and 1,000 
unaffected controls, 
2006-2010  
Case-Control 
study 
Determine whether the 
maternal serum levels of 
vit. D in the first 
trimester of pregnancy 
are altered in cases that 
develop preeclampsia 
and whether the levels 
are related to 
biochemical and 
biophysical markers of 
impaired placental 
perfusion and function. 
Among pregnancies that 
develop preeclampsia 
maternal serum total vit. 
D levels at 11-13 weeks 
of gestation are not 
altered.  
Zhao et al. 
(2012) 
1,814 females of 
childbearing age, 2003-
2006 
Cross-
sectional 
Examine prevalence and 
correlates of vit. D 
deficiency and 
inadequacy among US 
women of childbearing 
age 
Race/ethnicity other than 
for non-Hispanic White 
and obesity were 
associated with increased 
risk of vit. D deficiency, 
and dietary supplement 
use, milk consumption 
and sunlight exposure 
were associated with a 
decreased risk for vit. D 
deficiency and 
inadequacy, current 
smokers, history of 
diabetes and 
cardiovascular disease are 
associated with increased 
risk for vit. D deficiency. 
Zhou et al. 
(2014) 
2,960 pregnant women 
and 100 healthy controls 
in Guangzhou, China, 
September 2010-August 
2011 
Prospective 
observational 
study 
Assess maternal 
25(OH)D status and its 
association with 
pregnancy outcomes. 
There were no significant 
differences in most 
adverse pregnancy 
outcomes among pregnant 
women with different 
levels of vit. D at 16-20 
weeks of gestation except 
for higher prevalence of 
GDM and preterm 
delivery in women with 
high levels of vit. D.  
25(OH)D = 25-hydroxyvitamin D 
vit. D = vitamin D 
BMI = Body Mass Index 
GDM = Gestational Diabetes Mellitus 
25(OH)D3 = 25-hydroxyvitamin D₃ 
1,25(OH)₂D = 1,25-dihydroxyvitamin D₂ 
